ARTICOLE PUBLICATE 2025 (în curs)
Braicu, C., Ciocan, C., Bica, C., Zanoaga, O., Pop, L. A., Strilciuc, S., et al. (2025). Altered miRNA signatures in follicular fluid: Insights into infertility etiologies. Genes, 16(5), 537. https://doi.org/10.3390/genes16050537
Tâlvan, C.-D., Tâlvan, E.-T., Mohor, C. I., Budisan, L., Grecu, V., Mihalache, M., et al. (2025). The impact of miRNA expression on colon cancer severity, invasiveness, and localization. Cancers, 17(7), 1091. https://doi.org/10.3390/cancers17071091
Braicu, C., Muresanu, F. D., Isachesku, E., Bornstein, N., Filipovic, S. R., Strilciuc, S., et al. (2025). Role of miR-181 family members in stroke: Insights into mechanisms and therapeutic potential. International Journal of Molecular Sciences, 26(2), 440. https://doi.org/10.3390/ijms26020440
Beldean, A. C., Moldovan, R. C., Soritau, O., Strilciuc, S., Ciortea, R., Muresanu, F. D., et al. (2025). Composition and neurogenetic effects of embryonic cerebrospinal fluid: A systematic review. Neuromolecular Medicine, 27(1), 33. https://doi.org/10.1007/s12017-025-08829-1
Staszewski, J., Debiec, A., Strilciuc, S., Gniadek-Olejniczak, K., Piusinska-Macoch, R., Balo, D., et al. (2025). Efficacy of Cerebrolysin treatment as an add-on therapy to mechanical thrombectomy in acute ischemic stroke: 3-month follow-up of a prospective, open-label study. Translational Stroke Research. Advance online publication. https://doi.org/10.1007/s12975-025-01355-z
Pop-Crisan, A., Pirlog, R., Pruteanu, L. L., Busuioc, C., Pop, O. L., Pandey, D. P., et al. (2025). ATRX, OLIG2, MGMT, and IDH2 in glioblastoma: Essential molecular mechanisms and therapeutic significance. Medicina (Kaunas), 61(4), 697. https://doi.org/10.3390/medicina61040697
Homberg, V., Jianu, D. C., Stan, A., Strilciuc, S., Chelaru, V. F., Karlinski, M., et al. (2025). Speech therapy combined with Cerebrolysin in enhancing nonfluent aphasia recovery after acute ischemic stroke: ESCAS randomized pilot study. Stroke, 56(4), 937–947. https://doi.org/10.1161/STROKEAHA.124.049834
Baraian, A.-I., Raduly, L., Zanoaga, O., Iacob, B.-C., Barbu-Tudoran, L., Dinte, E., et al. (2025). Targeting JAK/STAT3 in glioblastoma cells using an alginate-PNIPAm molecularly imprinted hydrogel for the sustained release of ruxolitinib. International Journal of Biological Macromolecules, 298, 140025. https://doi.org/10.1016/j.ijbiomac.2025.140025
Nicolescu, A. C., Strilciuc, S., Lapadatu, R., Grad, D.-A., Vlădescu, C., & Olteanu, R. (2025). The economic burden of atopic dermatitis in Romania: A broad perspective. Frontiers in Public Health, 12, 1531042. https://doi.org/10.3389/fpubh.2024.1531042
Dragoș, H. M., Stan, A., Popa, L. L., Pintican, R., Feier, D., Drăghici, N. C., et al. (2025). Functional connectivity and MRI radiomics biomarkers of cognitive and brain reserve in post-stroke cognitive impairment prediction: A study protocol. Life, 15(1), 131. https://doi.org/10.3390/life15010131
Pana, A., Strilciuc, S., &Ileanu, B.-V. (2025). Dietary disruptors in Romania: Seasonality, traditions, and the COVID-19 pandemic. Nutrients, 17(1), 183. https://doi.org/10.3390/nu17010183
ARTICOLE PUBLICATE 2024
Arsenic Methyltransferase and Apolipoprotein E Polymorphism in Pregnant Women Exposed to Inorganic Arsenic in Drinking Water in Western Romania. (2024). International Journal of Molecular Sciences, 25, 1–13. https://doi.org/10.3390/ijms25063349
MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes. (2024). Biomedicines, 12, 1–17. https://doi.org/10.3390/biomedicines12010136
miRNA patterns in male LUSC patients – the 3-way mirror: Tissue, plasma and exosomes. (2024). Translational Oncology, 44, 1–8. https://doi.org/10.1016/j.tranon.2024.101951
MicroRNA-125b Is a Potential Predictor of Surgical Outcomes in Chronic Rhinosinusitis with Nasal Polyps. (2024). American Journal of Rhinology and Allergy, 38, 92. https://doi.org/10.1177/19458924231224343
Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics. (2024). International Journal of Molecular Sciences, 25, 1. https://doi.org/10.3390/ijms25115613
Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer. (2024). Cancers, 16, 1–23. https://doi.org/10.3390/cancers16040745
Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326. (2024). Cancers, 16, 1–20. https://doi.org/10.3390/cancers16122285
Current advances in circular RNA detection and investigation methods: Are we running in circles? (2024). Wiley Interdisciplinary Reviews: RNA, 15(3), e1850. https://doi.org/10.1002/wrna.1850
Differential effect of the duration of exposure on the carcinogenicity of cadmium in MCF10A mammary epithelial cells. (2024). Food and Chemical Toxicology, 186, 114523. https://doi.org/10.1016/j.fct.2024.114523
Memory-Guided Saccades in Subacute and Chronic Stroke: Secondary Data Analysis of the N-PEP-12 Clinical Study. (2024). Biomedicines, 12(8), 1–13. https://doi.org/10.3390/biomedicines12081678
Machine Learning Model Predicts Postoperative Outcomes in Chronic Rhinosinusitis With Nasal Polyps. (2024). Clinical Otolaryngology, 49, 776–784. https://doi.org/10.1111/coa.14208
Cost, Cost-effectiveness and Survival Impact Assessment for A Better Management of Colorectal Cancer Patients: A Single Centre Comprehensive Analysis. (2024). Journal of Gastrointestinal and Liver Diseases, 3, 1–7. https://doi.org/10.15403/jgld-5796
Expression and Functional Analysis of Immuno-Micro-RNAs mir-146a and mir-326 in Colorectal Cancer. (2024). Current Issues in Molecular Biology, 46, 7065–7085. https://doi.org/10.3390/cimb46070421
Sleep Health Patterns in Romania: Insights from a Nationwide Cross-Sectional Online Survey. (2024). Brain Sciences, 14, 1086. https://doi.org/10.3390/brainsci14111086
Evolution of Cognitive Disorders in Patients with Mild Cognitive Impairment (MCI) After Ischemic Stroke: Secondary Data Analysis from the Improved Health Care in Neurology and Psychiatry-Longer Life (IHCNP) Study. (2024). Neurology International, 16(6), 1626–1635. https://doi.org/10.3390/neurolint16060118
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer. (2024). Biomedicines, 12, 1–30. https://doi.org/10.3390/biomedicines12071489
The Evaluation of a 5-miRNA Panel in Patients with Periodontitis Disease. (2024). JDR Clinical & Translational Research, 10, 34–43. https://doi.org/10.1177/23800844241252395
miRNA-21 Inhibitor-Loaded Cationic Liposomes Development using the Quality by Design Approach. (2024). ChemistrySelect, 9(8), 1. https://doi.org/10.1002/slct.202303791
Neural Antibodies in First-episode Psychosis Patients with Warning Signs for Autoimmune Encephalitis. (2024). Clinical Psychopharmacology and Neuroscience, 22, 520–530. https://doi.org/10.9758/cpn.24.1164
Altered miRNA pattern in canine mammary tumors – pilot study. (2023). Animal Science Papers and Reports, 42, 1–14. https://doi.org/10.2478/aspr-2023-0032
Molecular Markers in Canine Mammary Tumors. (2024). Acta Veterinaria-Beograd, 74, 1–24. https://doi.org/10.2478/acve-2024-0012
Circular RNA-Mediated Regulation of Oral Tissue-Derived Stem Cell Differentiation: Implications for Oral Medicine and Orthodontic Applications. (2024). Stem Cell Reviews and Reports, 20(3), 656–671. https://doi.org/10.1007/s12015-024-10683-w
Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy? (2023). Stem Cell Reviews and Reports, 20, 206–217. https://doi.org/10.1007/s12015-023-10648-5
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in non-small cell lung cancer using a co-culture model. (2023). Biomolecules and Biomedicine, 24, 125–137. https://doi.org/10.17305/bb.2023.9272
Evaluation of miR-148a-3p and miR-106a-5p as Biomarkers for Prostate Cancer: Pilot Study. (2024). Genes, 15, 1–11. https://doi.org/10.3390/genes15050584
ARTICOLE PUBLICATE 2023
Bica, C., Tirpe, A., Nutu, A., Ciocan, C., Chira, S., Gurzau, E. S., et al. (2023). Emerging roles and mechanisms of semaphorins activity in cancer. Life Sciences, 318, 121499. https://doi.org/10.1016/j.lfs.2023.121499
Isacescu, E., Chiroi, P., Zanoaga, O., Nutu, A., Budisan, L., Pirlog, R., et al. (2023). Melanoma cellular signaling transduction pathways targeted by polyphenols action mechanisms. Antioxidants (Basel), 12(2), 407. https://doi.org/10.3390/antiox12020407
Drula, R., Braicu, C., Chira, S., &Berindan-Neagoe, I. (2023). Investigating circular RNAs using qRT-PCR; roundup of optimization and processing steps. International Journal of Molecular Sciences, 24(6), 5721. https://doi.org/10.3390/ijms24065721
Jurj, A., Zanoaga, O., Raduly, L., Morhan, V., Papi, Z., Ciocan, C., et al. (2023). Discovering the biological significance and therapeutic potential of miR-29b-3p in triple-negative breast cancer. International Journal of Molecular Sciences, 24(5), 5048. https://doi.org/10.3390/ijms24055048
Drula, R., Pardini, B., Fu, X., De Los Santos, M. C., Jurj, A., Pang, L., et al. (2023). 17β-Estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 120(23), e2122053120. https://doi.org/10.1073/pnas.2122053120
Chira, S., Ciocan, C., Bica, C., Calin, G. A., &Berindan-Neagoe, I. (2023). Artificial miRNAs derived from miR-181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs. FEBS Letters, 597(15), 1989–2005. https://doi.org/10.1002/1873-3468.14673
Berindan-Neagoe, I., & Lanzi, C. (2023). Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022. Frontiers in Oncology, 13, 1241793. https://doi.org/10.3389/fonc.2023.1241793
Romitan, M., Zanoaga, O., Budisan, L., Jurj, A., Raduly, L., Pop, L., et al. (2023). MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model. Biomolecules and Biomedicine. Advance online publication. https://doi.org/10.17305/bb.2023.9272
Farc, O., Budisan, L., Berindan-Neagoe, I., Braicu, C., Zanoaga, O., Zaharie, F., et al. (2023). A group of tumor-suppressive micro-RNAs changes expression coordinately in colon cancer. Current Issues in Molecular Biology, 45(2), 975–989. https://doi.org/10.3390/cimb45020063
Pirlog, B. O., Ilut, Ş., Pirlog, R., Chiroi, P., Nutu, A., Radutiu, D. I., et al. (2023). New perspective on DNA damage response pathway in glioblastoma: Classic biomarkers and emerging roles of ncRNAs. Expert Reviews in Molecular Medicine, 25, e18. https://doi.org/10.1017/erm.2023.10
Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Budisan, L., Puia, V. R., et al. (2023). Distinct morphological and molecular profiles of NAFLD and NAFLD-associated HCC revealed by immunohistochemistry and microRNA analysis. Journal of Gastrointestinal and Liver Diseases. Advance online publication. https://doi.org/10.15403/jgld-5065
Ciocan, R. A., Graur, F., Ciocan, A., Cismaru, C. A., Pintilie, S. R., Berindan-Neagoe, I., et al. (2023). Robot-guided ultrasonography in surgical interventions. Diagnostics (Basel), 13(14), 2456. https://doi.org/10.3390/diagnostics13142456
Micu, R., Gaia-Oltean, A. M. I., Budişan, L., Braicu, C., Irimie, A., &Berindan-Neagoe, I. (2023). The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis. Romanian Journal of Morphology and Embryology, 64(2), 159–164. https://doi.org/10.47162/RJME.64.2.05
Alexa, A. L., Jurj, A., Tomuleasa, C., Tigu, A. B., Hategan, R. M., & Ionescu, D. (2023). The effect of different anesthetic techniques on proliferation, apoptosis, and gene expression in colon cancer cells: A pilot in vitro study. Current Issues in Molecular Biology, 45(1), 738–751. https://doi.org/10.3390/cimb45010049
Ionescu, A., Ștefănescu, E., Strilciuc, Ș., Rafila, A., &Mureșanu, D. (2023). Correlating eye-tracking fixation metrics and neuropsychological assessment after ischemic stroke. Medicina (Kaunas), 59(8), 1361. https://doi.org/10.3390/medicina59081361
Gata, A., Neagoe, I. B., Leucuta, D. C., Budisan, L., Raduly, L., Trombitas, V. E., & Albu, S. (2023). MicroRNAs: Potential biomarkers of disease severity in chronic rhinosinusitis with nasal polyps. Medicina (Kaunas), 59(3), 550. https://doi.org/10.3390/medicina59030550
Fekete, Z., Tertan, B. O., Raduly, L., Eniu, D. T., Buiga, R., Galatar, M., et al. (2023). Prevalence of MMTV-like sequences in breast cancer samples in Romanian patients: Geographic differences compared to the Western world. Infectious Agents and Cancer, 18(1), 39. https://doi.org/10.1186/s13027-023-00486-y
Tefas, L. R., Toma, I., Sesarman, A., Banciu, M., Jurj, A., Berindan-Neagoe, I., et al. (2023). Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer. Journal of Liposome Research, 33(3), 234–250. https://doi.org/10.1080/08982104.2022.2153139
Tamas, T., Raduly, L., Berindan-Neagoe, I., Dinu, C., Botan, E., Bumbu, B., et al. (2023). The role of miRNA-221 and miRNA-34a in non-melanoma skin cancer of the head and neck region. Genes (Basel), 14(2), 503. https://doi.org/10.3390/genes14020503
Baru, O., Raduly, L., Bica, C., Chiroi, P., Budisan, L., Mehterov, N., et al. (2023). Identification of a miRNA panel with a potential determinant role in patients suffering from periodontitis. Current Issues in Molecular Biology, 45(3), 2248–2265. https://doi.org/10.3390/cimb45030145
Faur, C. I., Dinu, C., Toma, V., Jurj, A., Mărginean, R., Onaciu, A., et al. (2023). A new detection method of oral and oropharyngeal squamous cell carcinoma based on multivariate analysis of surface enhanced Raman spectra of salivary exosomes. Journal of Personalized Medicine, 13(5), 762. https://doi.org/10.3390/jpm13050762
Neamtiu, I. A., Bloom, M. S., Clark, J. M., Pop, C., Marincas, O., Berindan-Neagoe, I., et al. (2023). Urinary arsenic and spontaneous pregnancy loss: A hypothesis-generating case–control investigation in western Romania. Chemosphere, 335, 139167. https://doi.org/10.1016/j.chemosphere.2023.139167
Proiecte
• Program Sănătate „Dezvoltarea cercetării translaționale pentru vaccinuri, seruri și alte medicamente biologice – Acronim CANTAVAC 2.0”, Contract de finanțare nr. 98856/20.12.2024, cod MySMIS2021-326920, Responsabil proiect: Prof. Dr. Neagoe Ioana, perioada de derulare 20.12.2024 – 19.12.2029, buget UMF: 29.823.959,45 LEI
• PNRR – proiecte necompetitive Dezvoltarea cercetării genomice în România (ROGEN), Contract de Finanţare nr. 96006/17.12.2024, Responsabil proiect: –, perioada de derulare dec 2024 – dec 2029, buget: 13.807.406,01 RON
• HORIZON-HLTH-2021-DISEASE-04-04, Integrating AI in stroke neuroreabilitation, Contract 101057655-6/03.2024, Responsabil proiect CS II dr. Ștefan Strilciuc, perioada de derulare 03.2024 – 11.2026, buget 2.750.000,00 RON
• H2020-MSCA-RISE-2019-CONCRETE, Development of Cancer RNA Therapeutics CONCRETE, Contract nr. 872391/27.02.2020, Responsabil proiect Prof. dr. Ioana Neagoe, perioada de derulare 01.05.2020 – 30.10.2025, buget 524.400 RON
• PNRR-III-C9-2022-I8-81, Decoding the immuno-inflammatory axis in rare non-medullary thyroid cancer as an innovative approach for novel combinatory therapeutic approaches, Contract nr. 760067/23.05.2023, director de proiect Prof. dr. Netea Maier Romana Teodora, Prof. dr. Ioana Neagoe (UMF), perioada de derulare 03.07.2023 – 30.06.2026, buget 7.656.837,98 RON
• PNRR-III-C9-2022-I8-83, Lung Squamous Cell Carcinoma Therapeutic Targets Using Systems-Level Machine Learning Based On Single Cell RNA Sequencing, Contract nr. 760066/23.05.2023, director de proiect Prof. dr. Netea Maier Romana Teodora, Prof. dr. Ioana Neagoe (UMF), perioada de derulare 03.07.2023 – 30.06.2026, buget 7.637.115,98 RON
• H2020-MSCA-RISE-2018-RNADIAGON, Excellence in research and development of non-coding RNA DIAGnostics in Oncology – RNADIAGON, Contract nr. 824036/29.08.2018, responsabil de proiect Prof. dr. Ioana Neagoe, perioada de derulare 01.02.2019 – 31.07.2024, buget 563.017,50 RON
• PN-III-P2-2.1-PTE-2021-0176, Dezvoltarea de aplicații ale toxicogenomicii pentru screening-ul și evaluarea riscului în expunerea la contaminanți (arsen, plumb și cadmiu) din factorii de mediu, contract nr. 107PTE/30.06.202, responsabil proiect UMF CD I dr. Braicu Cornelia, perioada de derulare 23.06.2022 – 22.06.2024, buget UMF 593.104 RON
• PN-III-P4-ID-PCE-2020-2486, Modularea imunității instruite prin amplificatori ai vaccinării, Contract nr. PCE231/11.03.2021, director de proiect UMF Prof. dr. Mihai Netea, perioada de derulare 12.03.2021 – 31.10.2024, buget UMF 1.198.032 RON
• PN-III-P1-1.1-TE-2021-0939, Dezvoltarea unui vector de terapie genică prin modificarea bacteriofagului M13 pentru țintirea celulelor canceroase, Contract nr. 66/30.05.2022, director de proiect UMF CS III dr. Sergiu Chira, perioada de derulare 13.05.2022 – 31.10.2024, buget UMF 450.000 RON
• OC-2020-1-24729, COST action project CA21113 – Genome Editing to Treat Human Diseases – GenE-HumDi (15.05.2022 – 14.05.2024)
• PN-III-P1-1.1-PD-2021-0471, PD44/2022 – Evaluarea microARN-urilor din încărcătura exosomală în vederea identificării mecanismelor de rezistență la terapie în cancerul de sân triplu negativ, 01.04.2022 – 31.03.2024
• SEE 21-COP-0049 nr. înreg. 626/15.02.2022, Strategic interuniversity cooperation to improve research abilities for Ph.D. students for higher educational quality, 01.03.2022 – 30.09.2023
• CNFIS-FDI-2021-0595, Dezvoltarea și susținerea culturii antreprenoriale medicale în rândul studenților UMF Cluj-Napoca prin diseminare, formare și mentorat, 10.05.2021 – 17.12.2021
• CNFIS-FDI-2021-0594, „Creșterea capacității, competitivității și vizibilității cercetării a UMF Iuliu Hațieganu prin formarea și susținerea de echipe multidisciplinare în cercetarea de excelență“, 10.05.2021 – 17.12.2021
• 40PFE/30.12.2021, Creșterea performanțelor cercetării științifice, susținerea excelenței în cercetare și a inovării în medicină – PROGRES, 30.12.2021 – 17.06.2024
• PN-III-P4-ID-PCE-2020-1625, Testarea unor compuși mici care țintesc proteinkinazele activate mitogenic: succese și oportunități utilizând celule de cancer de sân triplu negativ, 04.01.2021 – 03.01.2023
• PN-III-P4-ID-PCE-2020-1756, ctr PCE 223/2021, Expunerea la Arsen din apă potabilă, expunerea la fum de țigară și efecte, 01.03.2021 – 29.02.2024
• POC/398/1/1 – ID 125371, Increasing the research capacity of UMF Iuliu Hațieganu Cluj-Napoca by developing a CLOUD-type infrastructure connected to global information resources – CYRUS, 07.05.2020 – 06.11.2022
• D-CARE 656/2020, Developing, piloting and validating smart care models in Danube region for supporting social innovation, improving competences and entrepreneurship – D-CARE, 07.2020 – 12.2022
• PN-III-P1-1.1-PD-2019-1095, ctr. PD202/2020, Evaluarea efectului gonadotrofinei corionice umane în transplantul de celule stem ca nouă metodă de stimulare a mobilizării pretransplant, 2020 – 2022
• PN-III-P2-2.1-PED-2019-2536, Nr contract: 557PED/2020, Dezvoltarea unui sistem inteligent combinat imagistic-citologic-molecular pentru stratificarea riscului, ghidarea diagnosticului și managementul în cancerul tiroidian – TIRCITOGEN, 02.11.2020 – 01.11.2022
• CNFIS-FDI-2020-0436, Dezvoltarea competențelor antreprenoriale în rândul studenților UMF Cluj-Napoca prin dezvoltarea de module educaționale experiențiale, 04.2020 – 12.2020
• PN-III-P2-2.1-SOL-2020-2-0324, Ctr Nr: 24SOL/2020, Dezvoltarea în regim de urgență a unor instrumente moleculare pentru evaluarea emergenței și re-emergenței COVID-19 – AcvaCov, 06.2020 – 12.2020
• H2020-FETFLAG-2018-01, 2020-ctr.nr 820431, Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease LifeTime, 2019 – 2020
• CNFIS-FDI-2019-0666, Susținerea și valorificarea cercetării de excelență în domeniul medicinei personalizate prin internaționalizare și creșterea vizibilității activităților de cercetare, 2019
• CNFIS-FDI-2019-0663, Dezvoltarea programelor suport pentru inițiativele antreprenoriale studențești în cadrul Universității de Medicină și Farmacie „Iuliu Hațieganu”, 2019
• PN-III-P1-1.2-PCCDI2017-0737, ctr 35 PCCDI, Maparea genomică a populației din zonele contaminate radioactiv și cu metale grele în vederea creșterii securității naționale – ARTEMIS, 2018 – 2020
• PN-III-P1-29PFE/18.10.2018, Creșterea performanțelor cercetării științifice și a transferului tehnologic în medicină translațională prin formarea unei noi generații de tineri cercetători – ECHITAS, 2018 – 2020
• PN-III-P4-ID-PCE-2016-0795, ctr 164/2017, Abordarea complexă a profilului expozomic în cancerele hormono-dependente de sân și prostată și influența acestuia în genomul tumoral – ACHILLE, 2017 – 2019
• H2020-WIDESPREAD-2016-2017, Teaming Phase 1, ID 763560, ctr. GA 763560/2017, Romanian Centre of Excellence for Systems Immunology – ROCSI, 2017 – 2018
• Cooperare internațională – American International School of Bucharest, ctr. 1110/23.07.2015, MicroRNAs biomarkers of response to chemotherapy and overall survival in colon cancer, 2016 – 2017
• POC-P_37_796, ctr 35/2016, Impactul clinic și economic al terapiilor personalizate țintite cu anti-microARNuri în reconvertirea rezistenței tumorilor maligne pulmonare – CANTEMIR, 2016 – 2020
• P_40_318, cod MySMIS 105774, Transfer de cunoștințe în aplicații clinice ale biogenomicii în oncologie și domenii conexe – BIOGENONCO, 2016 – 2023
• PN-II-RU-TE-2014-4-1464, ctr 307/2015, Tintirea căii de semnalizare TGFβ: o alternativă în terapia cancerului de sân – TGFtarget, 2015 – 2017
• PN-II-PT-PCCA-2013-4-2166, ctrr 128/2014, Noi strategii pentru îmbunătățirea calității vieții și supraviețuirea pacienților cu cancer: studii moleculare și clinice a genomului tumoral utilizând apă sărăcită în deuteriu – GenCanD, 2014 – 2017
• PN-II-PT-PCCA-2013-4-0030, ctr 196/2014, Modularea efectelor pro/anticarcinogenice ale agenților chimici de mediu în terapia multitintită în cancerul de sân – CANCERTER-p53, 2014 – 2017
• PN-III-P1-1.1-MCD-2016-0049, MCD Proiecte de mobilitate pentru cercetători cu experiență din diaspora, 2016
• ESR, ctr 14-10102/17.10.2014, BRCA1 and BRCA2 mutation analysis in Romanian population: a study of genotype-phenotype correlation at diagnosis with prospective disease outcome and survival, 2014 – 2016
• PN-II-PT-PCCA-2011-3.1-1328, ctr 96/2012, Analiza miARN ca posibili biomarkeri cu valoare de predicție pentru tratamentul cancerului de col uterin, în relație cu expunerea la factorii de mediu, arsen, ftalați și cotinina – Cervicall-arsen-array, 2012 – 2016
• PN-II-PT-PCCA-2011-3.1-1221, ctr 125/2012, Sisteme inteligente de predicție a recurenței și progresiei în cancerul superficial de vezică bazate pe inteligența artificială și date microarray: mRNA tumoral și microRNA plasmatic – IntelUro, 2012 – 2016
• POSCEE 2010, Contract 228/06.08.2010, Impactul clinic și economic al identificării profilelor moleculare transcriptomice și proteomice în terapia neoadjuvantă a cancerului de sân triplu negativ – BREASTIMPACT, 2010 – 2014
ARTICOLE PUBLICATE 2022
Moloudizargari M, Asghari MH, Nabavi SF, Gulei D, Berindan-Neagoe I, Bishayee A, Nabavi SM. Targeting Hippo signaling pathway by phytochemicals in cancer therapy. Seminars In Cancer Biology, 2022 May;80:183-194. doi: 10.1016/j.semcancer.2020.05.005 17.012
Braicu C, Zanoaga O, Zimta AA, Tigu AB, Kilpatrick KL, Bishayee A, Nabavi SM, Berindan-Neagoe I. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells Seminars In Cancer Biology, 2022 May;80:218-236. doi: 10.1016/j.semcancer.2020.05.015. 17.012
Pirlog R, Piton N, Lamy A, Guisier F, Berindan-Neagoe I, Sabourin JC, Marguet F. Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas Cancers (Basel). 2022 Feb 17;14(4):1030. doi: 10.3390/cancers14041030 6.575
Dudea-Simon M, Mihu D, Pop LA, Ciortea R, Malutan AM, Diculescu D, Ciocan CA, Cojocneanu RM, Simon V, Bucuri C, Mocan-Hognogi R, Braicu C, Berindan-Neagoe I. Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer – International Journal Of Molecular Sciences, 2022 May 27;23(11):6054. doi: 10.3390/ijms23116054.6.208
Pirlog R, Chiroi P, Rusu I, Jurj AM, Budisan L, Pop-Bica C, Braicu C, Crisan D, Sabourin JC, Berindan-Neagoe I. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer, International Journal Of Molecular Sciences 2022 May 11;23(10):5346, doi: 10.3390/ijms23105346. 6.208
Pruteanu LL, Braicu C, Módos D, Jurj MA, Raduly LZ, Zănoagă O, Magdo L, Cojocneanu R, Paşca S, Moldovan C, Moldovan AI, Ţigu AB, Gurzău E, Jäntschi L, Bender A, Berindan-Neagoe I. Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines, International Journal Of Molecular Sciences 2022 Apr 26;23(9):4784. doi: 10.3390/ijms23094784. 6.208
Danku AE, Dulf EH, Braicu C, Jurj A, Berindan-Neagoe I; Organ-On-A-Chip: A Survey of Technical Results and Problems Frontiers In Bioengineering And Biotechnology, 2022 Feb 10;10:840674. doi: 10.3389/fbioe.2022.840674. eCollection 2022. PMID: 35223800 6.064
Lazar V, Raynaud J, Magidi S, Bresson C, Martini JF, Galbraith S, Wunder F, Onn A, Batist G, Girard N, Lassen U, Pramesh CS, Al-Omari A, Ikeda S, Berchem G, Blay JY, Solomon B, Felip E, Tabernero J, Rubin E, Philip T, Porgador A, Berindan-Neagoe I, Schilsky RL, Kurzrock R. – Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung Therapeutic Advances In Medical Oncology, 2022 Oct 28;14:17588359221133893. doi: 10.1177/17588359221133893 5.485
Ismaiel A, Spinu M, Socaciu C, Budisan L, Leucuta DC, Popa SL, Chis BA, Berindan-Neagoe I, Olinic DM, Dumitrascu DL. Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis Nutrition & Diabetes. 2022 Jan 18;12(1):4. doi: 10.1038/s41387-022-00182-7. PMID: 35042855 4.725
Pop-Bica C, Ciocan CA, Braicu C, Haranguș A, Simon M, Nutu A, Pop LA, Slaby O, Atanasov AG, Pirlog R, Al Hajjar N, Berindan-Neagoe I. Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes Journal Of Personalized Medicine, 2022, 12 (3), nr 453 3.508
Achimas-Cadariu P, Kubelac P, Irimie A, Berindan-Neagoe I, Rühli F Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present – Journal Of Ovarian Research, 2022 Jun 3;15(1):67, doi: 10.1186/s13048-022-01004-1 5.506
Aghiorghiesei O, Zanoaga O, Nutu A, Braicu C, Campian RS, Lucaciu O, Berindan Neagoe I. The World of Oral Cancer and Its Risk Factors Viewed from the Aspect of MicroRNA Expression Patterns. Genes (Basel). 2022 Mar 26;13(4):594. doi: 10.3390/genes13040594. PMID: 35456400 4.141
Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I. MicroRNA Dysregulation in Prostate Cancer, Pharmacogenomics & Personalized Medicine. 2022 Mar 10;15:177-193. doi: 10.2147/PGPM.S348565. eCollection 2022.PMID: 35300057 2.606
Vidra R, Ciuleanu TE, Nemeș A, Pascu O, Heroiu AM, Antone N, Vidrean AI, Oprean CM, Pop LA, Berindan-Neagoe I, Eniu R, Eniu A. Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients International Journal Of Environmental Research And Public Health. 2022 Apr 4;19(7):4314. doi: 10.3390/ijerph19074314.PMID: 35409996 4.614
Kasi Pandima Devi , Mahmoud Reza Pourkarim , Marijn Thijssen , Antoni Sureda Maryam Khayatkashani, Cosmin Andrei Cismaru , Ioana Berindan Neagoe , Solomon Habtemariam , Soha Razmjouei, Hamid Reza Khayat Kashani A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2, Pharmacological Reports, 2022, 2022 Apr;74(2):425-430. doi: 10.1007/s43440-021-00344-x 3.919
Domsa EM, Berindan-Neagoe I, Budisan L, Braicu C, Para I, Tantau AI, Orasan OH, Ciobanu L, Pop TA, Filip GA, Leach N, Negrean V, Matei D, Andreica V., Expression of Selected Genes and Circulating microRNAs in Patients with Celiac Disease, Medicina-Lithuania. 2022 Jan 25;58(2):180. doi: 10.3390/medicina58020180. 2.948
Ovidiu Aghiorghiesei, Oana Zanoaga, Lajos Raduly, Alexandra Iulia Aghiorghiesei, Paul Chiroi,Andrada Trif,Rares Buiga, Liviuta Budisan,Ondine Lucaciu, Laura Ancuta Pop,Cornelia Braicu,Radu Campian and Ioana Berindan-Neagoe – „Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?- Current Issues In Molecular Biology. 2022, 44(4), 1754-1767; https://doi.org/10.3390/cimb44040121 – 16 Apr 2022- 2.976
Constantin Busuioc, Rodica Daniela Birla, Flavia Ultimescu, Sorin Duţulescu, Eugenia Panaitescu, Ioana Berindan-Neagoe, Abberant Immunohistochemical Expression of OCT3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in Colorectal Adenocarcinoma, Chirurgia (Bucur) . 2022 Oct;117(5):544-555. doi: 10.21614/chirurgia.2782.0.26
Calvo-Lozano O, García-Aparicio P, Raduly LZ, Estévez MC, Berindan-Neagoe I, Ferracin M, Lechuga LM.- One-Step and Real-Time Detection of microRNA-21 in Human Samples for Lung Cancer Biosensing Diagnosis, Analytical Chemistry, OCT 2022, Volume 94, Issue 42, Page14659-14665, DOI10.1021/acs.analchem.2c02895 8.008
Jurj A, Ionescu C, Berindan-Neagoe I, Braicu C. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Journal Of Experimental & Clinical Cancer Research, SEP 16 2022, Volume 41, Issue 1, Article Number 276, DOI 10.1186/s13046-022-02484-1 12.658
Farc, O; Berindan-Neagoe, I; Zaharie, F; Budisan, L; Zanoaga, O; Cristea, V ,- A role for serum cytokines and cell adhesion molecules in the non-invasive diagnosis of colorectal cancer, Oncology Letters, SEP 2022, Volume 24, Issue 3, Article Number 323, DOI 10.3892/ol.2022.13443 3.111
Chira S, Nutu A, Isacescu E, Bica C, Pop L, Ciocan C, Berindan-Neagoe I. – Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research, Cells, SEP 2022, Volume 11, Issue 18, Article Number 2781, DOI 10.3390/cells11182781 7.666
Kacso TP, Zahu R, Tirpe A, Paslari EV, Nuțu A, Berindan-Neagoe I., Reactive Oxygen Species and Long Non-Coding RNAs, an Unexpected Crossroad in Cancer Cells, International Journal Of Molecular Sciences, SEP 2022, Volume 23 Issue 17, Article Number 10133, DOI 10.3390/ijms231710133 6.208
Cismaru CA, Pirlog R, Calin GA, Berindan-Neagoe I. – Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding, Stem Cell Reviews And Reports, DEC 2022, Volume 18, Issue 8, Page 2549-2565, DOI 10.1007/s12015-022-10428-7 6.692
Toma I, Porfire AS, Tefas LR, Berindan-Neagoe I, Tomuță I. – A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA Pharmaceutics, JUL 2022, Volume 14, Issue 7, Article Number 1482, DOI 10.3390/pharmaceutics14071482 6.525
Adrian-Alexandru Someșan, Sabina-Mădălina Vieriu, Alexandru Crăciun ,Cristian Silvestru, Paul Chiroi, Andreea Nutu, Ancuta Jurj, Raduly Lajos, Ioana Berindan-Neagoe, Richard A. Varga C , O ‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity Applied Organometallic Chemistry 2022, 36, e6540 . 4.072
Lazar V, Girard N, Raymond E, Martini JF, Galbraith S, Raynaud J, Bresson C, Solomon B, Magidi S, Nechushtan H, Onn A, Berger R, Chen H, Al-Omari A, Ikeda S, Lassen U, Sekacheva M, Felip E, Tabernero J, Batist G, Spatz A, Pramesh CS, Girard P, Blay JY, Philip T, Berindan-Neagoe I, Porgador A, Rubin E, Kurzrock R, Schilsky RL. Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies JCO Precision Oncology 2022 Sep;6:e2200072. doi: 10.1200/PO.22.00072. 5.479
Rusu I, Pirlog R, Chiroi P, Nutu A, Puia VR, Fetti AC, Rusu DR, Berindan-Neagoe I, Al Hajjar N.- The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC International Journal Of Molecular Sciences, 2022 Oct15;23(20):12370. doi: 10.3390/ijms232012370. 6.208
Neamtiu IA, Surcel M, Begum TF, Gurzau ES, Berindan-Neagoe I, Braicu C, Rotar I, Muresan D, Bloom MS. Specific lifestyle factors and in vitro fertilization outcomes in Romanian women: a pilot study Peer J. 2022 Oct 4;10:e14189. doi: 10.7717/peerj.14189. eCollection 2022. 3.061
Cismaru CA, Chira S, Cismaru GL, Nutu AM, Netea MG, Berindan-Neagoe I. Assessment of the frequency of coughing and sneezing triggered by nasopharyngeal swabbing in the pandemic setting – Scientific Reports, 2022 Jun 27;12(1):10874. doi: 10.1038/s41598-022-14755-0. 4.997
Burghelea D, Moisoiu T, Ivan C, Elec A, Munteanu A, Iancu ȘD, Truta A, Kacso TP, Antal O, Socaciu C, Elec FI, Kacso IM.The Use of Machine Learning Algorithms and the Mass Spectrometry Lipidomic Profile of Serum for the Evaluation of Tacrolimus Exposure and Toxicity in Kidney Transplant Recipients. Biomedicines. 2022 May 17;10(5):1157. doi: 10.3390/biomedicines10051157.PMID: 35625894 4.757
Stefancu A, Moisoiu V, Desmirean M, Iancu SD, Tigu AB, Petrushev B, Jurj A, Cozan RG, Budisan L, Fetica B, Roman A, Dobie G, Turcas C, Zdrenghea M, Teodorescu P, Pasca S, Piciu D, Dima D, Bálint Z, Leopold N, Tomuleasa CSERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathy.. Spectrochimica Acta Part A-Molecular And Biomolecular Spectroscopy. 2022 Jan 5;264:120216. doi: 10.1016/j.saa.2021.120216. Epub 2021 Jul 21. 4.831
Ticala M, Rusu CC, Moldovan D, Potra AR, Tirinescu DC, Coman AL, Bondor CI, Budisan L, Kacsó IM Hemodialysis Patients with Higher Serum Levels of Soluble Receptor for Advanced Glycation End Products Have an Increased Risk for Arteriovenous Fistula Failure.. Blood Purification. 2022;51(9):764-771. doi: 10.1159/000519879. Epub 2021 Nov 18. PMID: 34794141 3.348
Ticala M, Rusu CC, Moldovan D, Potra AR, Tirinescu DC, Coman AL, Bondor CI, Budisan L, Kacso IM Relationship between vascular cell adhesion molecule-1 (VCAM-1), soluble receptor for advanced glycation end products (sRAGE) and functional hemodynamic parameters of arteriovenous fistula. Journal Of Vascular Access. 2022 Jan;23(1):67-74. doi: 10.1177/1129729820976264. 2.326
Rosu RO, Lupsor A, Necula A, Cismaru G, Cainap SS, Iacob D, Lazea C, Cismaru A, Negru AG, Pop D, Gusetu G. Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.Diagnostics (Basel). 2022 Feb 14;12(2):489. doi: 10.3390/diagnostics12020489.PMID: 35204578 3.992
Ilut S, Pirlog BO, Pirlog R, Nutu A, Vacaras V, Armean SM Recent Advances on the Roles of PCSK-9 Inhibitors in the Management of Acute Ischemic Stroke Patients. International Journal of Molecular Sciences. 2022 Sep 6;23(18):10221. doi: 10.3390/ijms231810221.PMID: 36142135. 6.208
Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, Pop LA Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis..Front Microbiol. 2022 Jun 20; 13:908525. doi: 10.3389/fmicb.2022.908525. eCollection 2022.PMID: 35794916. 6.064
Faur, C.I.; Roman, R.C.; Jurj, A.; Raduly, L.; Almășan, O.; Rotaru, H.; Chirilă, M.; Moldovan, M.A.; Hedeșiu, M.; Dinu, C.. Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma Medicina 2022, 58, 1478. https://doi.org/10.3390/medicina58101478 2.948
Cosmin Andrei Cismaru, Radu Pirlog, George Adrian Calin, Ioana Berindan‑Neagoe. Stem Cells in the Tumor Immune Microenvironment –Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding. Stem Cell Reviews and Reports (2022) 18:2549–2565. https://doi.org/10.1007/s12015-022-10428-7 6,692
Haranguș A, Lajos R, Budisan L, Zanoaga O, Ciocan C, Bica C, Pirlog R, Simon I, Simon M, Braicu C, Berindan-Neagoe I. Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods. J Pers Med. 2022 Dec 13;12(12):2056. doi: 10.3390/jpm12122056. PMID: 36556276; PMCID: PMC9780989.
Mehterov N, Sacconi A, Pulito C, Vladimirov B, Haralanov G, Pazardjikliev D, Nonchev B, Berindan-Neagoe I, Blandino G, Sarafian V. A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa. Front Oncol. 2022 Dec 1; 12:1072579. doi: 10.3389/fonc.2022.1072579. PMID: 36531016; PMCID: PMC9753689.
Antoniraj MG, Devi KP, Berindan-Neagoe I, Nabavi SF, Kashani HRK, Aghaabdollahian S, Afkhami F, Jeandet P, Lorigooini Z, Khayatkashani M, Nabavi SM. Oral microbiota in cancer: Could the bad guy turn good with application of polyphenols? Expert Rev Mol Med. 2022 Dec 13:1-63. doi: 10.1017/erm.2022.39. Epub ahead of print. PMID: 36511134.
Mehterov N, Sacconi A, Pulito C, Vladimirov B, Haralanov G, Pazardjikliev D, Nonchev B, Berindan-Neagoe I, Blandino G, Sarafian V. A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa. Front Oncol. 2022 Dec 1; 12:1072579. doi: 10.3389/fonc.2022.1072579. PMID: 36531016; PMCID: PMC9753689. 5.738
Antoniraj MG, Devi KP, Berindan-Neagoe I, Nabavi SF, Kashani HRK, Aghaabdollahian S, Afkhami F, Jeandet P, Lorigooini Z, Khayatkashani M, Nabavi SM. Oral microbiota in cancer: Could the bad guy turn good with application of polyphenols? Expert Rev Mol Med. 2022 Dec 13:1-63. doi: 10.1017/erm.2022.39. Epub ahead of print. PMID: 36511134. 7.615
Tefas LR, Toma I, Sesarman A, Banciu M, Jurj A, Berindan-Neagoe I, Rus L, Stiufiuc R, Tomuta I, Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer Journal Of Liposome Research. 2022 Dec 6:1-58. doi: 10.1080/08982104.2022.2153139. 5.586
Jurj A, Qian D, Calin GA, Litchfield K. At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets Annals Of Oncology. 2022 Dec;33(12):1214-1216. doi: 10.1016/j.annonc.2022.10.507. 51.769
Jurj A, Pasca S, Braicu C, Rusu I, Korban SS, Berindan-Neagoe I. Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling? Seminars In Cancer Biology. 2021 Dec 9:S1044-579X(21)00295-9. doi: 10.1016/j.semcancer.2021.12.002. 17.012
Lisencu LA, Roman A, Visan S, Bonci EA, Pașca A, Grigorescu E, Mustea E, Cismaru A, Irimie A, Lisencu C, Balacescu L, Balacescu O, Tudoran O The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy Medicina (Kaunas) 2022 Oct 20;58(10):1494. doi: 10.3390/medicina58101494. 2.948
Baldasici O, Balacescu L, Cruceriu D, Roman A, Lisencu C, Fetica B, Visan S, Cismaru A, Jurj A, Barbu-Tudoran L, Pileczki V, Vlase L, Tudoran O, Balacescu O. Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients International Journal Of Molecular Sciences. 2022 Oct 20;23(20):12625. doi: 10.3390/ijms232012625. 6.208
ARTICOLE PUBLICATE 2021
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery. 2021 Jan 28:1-17. doi: 10.1038/s41573-020-00114-z. 112.288
Oana Baru, Andreea Nutu, Cornelia Braicu, Cosmin Andrei Cismaru, Ioana Berindan-Neagoe, Smaranda Buduru, Mîndra Badea Angiogenesis in Regenerative Dentistry: Are We Far Enough for Therapy? International Journal Of Molecular Sciences, 2021 Jan; 22(2): 929. – 6.208
Pirlog R, Cismaru A, Nutu A, Berindan-Neagoe I. Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization. International Journal Of Molecular Sciences 2021, 13;22(2):746. doi: 10.3390/ijms22020746 – 6.208
Cismaru CA, Cismaru GL, Nabavi SF, Ghanei M, Burz CC, Nabavi SM, Berindan Neagoe I. Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19 Journal Of Cellular And Molecular Medicine. 2021, 25(1):591-595. doi: 10.1111/jcmm.15927.- 5.295
Drula R, Pirlog R, Trif M, Slaby O, Braicu C, Berindan-Neagoe I circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks. Biochimica Et Biophysica Acta-Molecular Basis Of Disease. 2021 Jan 26;1867(5):166045. doi: 10.1016/j.bbadis.2020.166045 – 6.633
Nabavi SF, Habtemariam S, Berindan-Neagoe I, Cismaru CA, Schaafsma D, Ghavami S, Banach M, Aghaabdollahian S, Nabavi SM Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell. CTS-Clinical And Translational Science 2021 Mar;14(2):431-433. doi: 10.1111/cts.12949.- 4.516
Cenariu D, Fischer-Fodor E, Țigu AB, Bunea A, Virág P, Perde-Schrepler M, Toma VA, Mocan A, Berindan-Neagoe I, Pintea A, Crișan G, Cenariu M, Maniu A Zeaxanthin-Rich Extract from Superfood Lycium barbarum Selectively Modulates the Cellular Adhesion and MAPK Signaling in Melanoma versus Normal Skin Cells In Vitro. Molecules. 2021 Jan 11;26(2):333. doi: 10.3390/molecules26020333. – 4.927
Cismaru CA, Cismaru GL, Seyed Nabavi F, Seyed Nabavi M, Berindan-Neagoe I. COVID-19 and antimalarials. Have we been doing it wrong all along? European Journal Of Pharmacology, 2021, 15;891:173694 – 5.195
Călin Căinap, Sânziana Cetean-Gheorghe, Laura Ancuta Pop, Daniel Corneliu Leucuta, Doina Piciu, Andra Mester, Cătălin Vlad, Crişan Ovidiu, Alexandra Gherman, Cristina Crişan , Alina Bereanu, Ovidiu Bălăcescu, Anne Marie Constantin, Irina Dicu, Loredana Bălăcescu, Adina Stan , Patriciu Achimaş-Cadariu , Simona Căinap Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia Medicina (Kaunas) 2021 Jun 30;57(7):675. doi: 10.3390/medicina57070675 – 2.948
Paul Kubelac, Cornelia Braicu , Lajos Raduly , Paul Chiroi , Andreea Nutu , Roxana Cojocneanu , Liviuta Budisan, Ioana Berindan-Neagoe , Patriciu Achimas-Cadariu Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer Diagnostics (Basel) . 2021 Feb 19;11(2):344. doi: 10.3390/diagnostics11020344 – 3.706
Gaia-Oltean AI, Braicu C, Gulei D, Ciortea R, Mihu D, Roman H, Irimie A, Berindan-Neagoe I. Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations Experimental And Therapeutic Medicine, 2021, Mar;21(3):243, doi: 10.3892/etm.2021.9674. Epub 2021 Jan 22.- 1.785
Florian IA, Beni L, Moisoiu V, Timis TL, Florian IS, Balașa A, Berindan-Neagoe I.‘De Novo’ Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases Medicina-Lithuania. 2021 Feb 26;57(3):201. doi: 10.3390/medicina57030201- 2.948
Osan C, Chira S, Nutu AM, Braicu C, Baciut M, Korban SS, Berindan-Neagoe I.The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging Biomarkers in Oral Cancer Management – PubMed (nih.gov) Genes (Basel). 2021 Dec 15;12(12):1989. doi: 10.3390/genes12121989 – 4.141
Marc A, Pop C, Sitar-Taut AV, Budisan L, Berindan-Neagoe I, Pop D. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study, BMC Cardiovascular Disorders. 2021 Dec 20;21(1):607. doi: 10.1186/s12872-021-02424-5.PMID: 34930125 – 2.174
Sangsriwong, M., Cismaru, G., Puiu, M., Simu, G., Istratoaie, S., Muresan, L., Gusetu, G., Cismaru, A., Pop, D., Zdrenghea, D., & Rosu, R. (2021). Formula to estimate left atrial volume using antero-posterior diameter in patients with catheter ablation of atrial fibrillation. Medicine, 2021, 100(29), e26513. https://doi.org/10.1097/MD.0000000000026513. -1.817
Jurj A, Pasca S, Braicu C, Rusu I, Korban SS, Berindan-Neagoe I. Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling? Seminars In Cancer Biology. 2021 Dec 9:S1044-579X(21)00295-9. doi: 10.1016/j.semcancer.2021.12.002. Online ahead of print.PMID: 34896267 – 17.012
Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe I. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions International Journal Of Molecular Sciences 2021 Nov 19;22(22):12491. doi: 10.3390/ijms222212491.PMID: 34830370- 6.208
Ismaiel A, Spinu M, Budisan L, Leucuta DC, Popa SL, Chis BA, Berindan-Neagoe I, Olinic DM, Dumitrascu DLRelationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease. Journal Of Clinical Medicine . 2021 Nov 7;10(21):5194. doi: 10.3390/jcm10215194.PMID: 34768714 – 4.964
Renaudineau Y, Berindan-Neagoe I, Stanciu LA Editorial: Role of Macrophage MicroRNAs in Inflammatory Diseases and Cancer. Frontiers In Immunology . 2021 Sep 13;12:764525. doi: 10.3389/fimmu.2021.764525. eCollection 2021.PMID: 34594345 – 8.787
Budisan L, Zanoaga O, Braicu C, Pirlog R, Covaliu B, Esanu V, Korban SS, Berindan-Neagoe I.Links between Infections, Lung Cancer, and the Immune System. International Journal Of Molecular Sciences. 2021 Aug 30;22(17):9394. doi: 10.3390/ijms22179394.PMID: 34502312- 6.208
Zanoaga O, Braicu C, Chiroi P, Andreea N, Hajjar NA, Mărgărit S, Korban SS, Berindan-Neagoe I.The Role of miR-155 in Nutrition: Modulating Cancer-Associated Inflammation. Nutrients. 2021 Jun 29;13(7):2245. doi: 10.3390/nu13072245.PMID: 34210046 – 6.706
Florian IA, Buruiana A, Timis TL, Susman S, Florian IS, Balasa A, Berindan-Neagoe I An Insight into the microRNAs Associated with Arteriovenous and Cavernous Malformations of the Brain.Cells. 2021 Jun 2;10(6):1373. doi: 10.3390/cells10061373.PMID: 34199498 – 7.66
Laprovitera N, Riefolo M, Porcellini E, Durante G, Garajova I, Vasuri F, Aigelsreiter A, Dandachi N, Benvenuto G, Agostinis F, Sabbioni S, Berindan Neagoe I, Romualdi C, Ardizzoni A, Trerè D, Pichler M, D’Errico A, Ferracin M.MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary. Molecular Oncology 2021 Oct;15(10):2732-2751. doi: 10.1002/1878-0261.13026. Epub 2021 Jun 23.PMID: 34075699- 7.449
Busuioc C, Ciocan-Cartita CA, Braicu C, Zanoaga O, Raduly L, Trif M, Muresan MS, Ionescu C, Stefan C, Crivii C, Al Hajjar N, Mǎrgǎrit S, Berindan-Neagoe I.Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma.Journal Of Personalized Medicine . 2021 May 26;11(6):476. doi: 10.3390/jpm11060476.PMID: 34073426- 3.508
Cenariu D, Zimta AA, Munteanu R, Onaciu A, Moldovan CS, Jurj A, Raduly L, Moldovan A, Florea A, Budisan L, Pop LA, Magdo L, Albu MT, Tonea RB, Muresan MS, Ionescu C, Petrut B, Buiga R, Irimie A, Gulei D, Berindan-Neagoe I.Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene. Pharmaceutics. 2021 May 6;13(5):664. doi: 10.3390/pharmaceutics13050664.PMID: 34066331 – 6.525
Gaia-Oltean AI, Pop LA, Cojocneanu RM, Buse M, Zimta AA, Kubelac P, Irimie A, Coza OF, Roman H, Berindan-Neagoe I. The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma. American Journal Of Cancer Research . 2021 Apr 15;11(4):1754-1769. eCollection 2021.PMID: 33948387 – 5.942
Lazar V, Magidi S, Girard N, Savignoni A, Martini JF, Massimini G, Bresson C, Berger R, Onn A, Raynaud J, Wunder F, Berindan-Neagoe I, Sekacheva M, Braña I, Tabernero J, Felip E, Porgador A, Kleinman C, Batist G, Solomon B, Tsimberidou AM, Soria JC, Rubin E, Kurzrock R, Schilsky RL. Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival. NPJ Precision Oncology . 2021 Apr 28;5(1):33. doi: 10.1038/s41698-021-00171-6.PMID: 33911192 – 10.123
Zaki Milhem, Paul Chiroi, Andreea Nutu, Maximilian Ilea, Mihaela Lupse, Oana Zanoaga and Ioana Berindan-Neagoe –Non-Coding RNAs and Reactive Oxygen Species-Symmetric Players of the Pathogenesis Associated with Bacterial and Viral Infections Symmetry-Basel, 2021, 13( 7), 1307; https://doi.org/10.3390/sym13071307 –2.94
Braicu C Functional Genomics in Health and Disease. International Journal Of Molecular Sciences. 2021 Nov 30;22(23):12944. doi: 10.3390/ijms222312944.PMID: 34884749 –6.208
Beleaua MA, Jung I, Braicu C, Milutin D, Gurzu S Relevance of BRAF Subcellular Localization and Its Interaction with KRAS and KIT Mutations in Skin Melanoma.. International Journal Of Molecular Sciences. 2021 Nov 3;22(21):11918. doi: 10.3390/ijms222111918.PMID: 34769348 –6.208
Beleaua MA, Jung I, Braicu C, Milutin D, Gurzu S. SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma. Life-Basel 2021 Mar 27;11(4):281. doi: 10.3390/life11040281 – 3.253
Nicoară SD, Brie I, Jurj A, Sorițău O. The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View. International Journal Of Molecular Sciences. 2021 Oct 14;22(20):11077. doi: 10.3390/ijms222011077. PMID: 34681739; PMCID: PMC8540760.- 6.208
Gurzu S, Sugimura H, Szederjesi J, Szodorai R, Braicu C, Kobori L, Fodor D, Jung I Interaction between cadherins, vimentin, and V-set and immunoglobulin domain containing 1 in gastric-type hepatocellular carcinoma. Histochemistry And Cell Biology. 2021 Oct;156(4):377-390. doi: 10.1007/s00418-021-02006-8. Epub 2021 Jun 25.PMID: 34170400 2.531
Moisoiu, V., Sas, V., Stefancu, A., Iancu, S. D., Jurj, A., Pasca, S., Iluta, S., Zimta, A.-A., Tigu, A. B., Teodorescu, P., Turcas, C., Blag, C., Dima, D., Popa, G., Arghirescu, S., Man, S., Colita, A., Leopold, N., & Tomuleasa, C. (2021). SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome. Frontiers in Bioengineering and Biotechnology, 2021 Jul 23;9:703268. doi: 10.3389/fbioe.2021.703268 – 6.064
Faur CI, Rotaru H, Osan C, Jurj A, Roman RC, Moldovan M, Chirila M, Hedesiu M. Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Maxillofacial Plastic and Reconstructive Surgery. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9. PMID: 34191144.- 0.7
Iluta S, Pasca S, Gafencu G, Jurj A, Terec A, Teodorescu P, Selicean C, Jitaru C, Preda A, Cenariu D, Constantinescu C, Iordache M, Tigu B, Munteanu R, Feder R, Dima D, Zdrenghea M, Gulei D, Ciuleanu TE, Tomuleasa C. Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy. Journal Of Cellular And Molecular Medicine, 2021 Jun 16. doi: 10.1111/jcmm.16513. PMID: 34132464. – 5.295
Pasca S, Jurj A, Constantinescu C, Zdrenghea M, Tomuleasa C. Implications of TET2 in CAR-T Cell Activity and Target Response to CAR-T Cell Therapy: Lessons Learned from T Cells. Critical Reviews in Immunology 2021;41(1):13-21. doi: 10.1615/CritRevImmunol.2020036946. PMID: 33822522.- 1.735
Pasca S, Jurj A, Zdrenghea M, Tomuleasa C. The Potential Equivalents of TET2 Mutations. Cancers. 2021; 13(7):1499, doi: 10.3390/cancers13071499 – 6.575
Țigu AB, Moldovan CS, Toma VA, Farcaș AD, Moț AC, Jurj A, Fischer-Fodor E, Mircea C, Pârvu M. Phytochemical Analysis and In Vitro Effects of Allium fistulosum L. and Allium sativum L. Extracts on Human Normal and Tumor Cell Lines: A Comparative Study. Molecules. 2021 Jan 22;26(3):574. doi: 10.3390/molecules26030574. PMID: 33499159; PMCID: PMC7866094. – 4.927
Deak D, Gorcea-Andronic N, Sas V, Teodorescu P, Constantinescu C, Iluta S, Pasca S, Hotea I, Turcas C, Moisoiu V, Zimta AA, Galdean S, Steinheber J, Rus I, Rauch S, Richlitzki C, Munteanu R, Jurj A, Petrushev B, Selicean C, Marian M, Soritau O, Andries A, Roman A, Dima D, Tanase A, Sigurjonsson O, Tomuleasa C. A narrative review of central nervous system involvement in acute leukemias. Annals Of Translational Medicine, 2021;9(1):68. 3.616
Calin Cainap, Ovidiu Balacescu , Simona Sorana Cainap, Laura-Ancuta Pop Next Generation Sequencing Technology in Lung Cancer Diagnosis Biology (Basel), 2021 Sep 3;10(9):864. doi: 10.3390/biology10090864.- 5.168
Cainap C, Ungur RA, Bochis OV, Achimas P, Vlad C, Havasi A, Vidrean A, Farcas A, Tat T, Gherman A, Piciu A, Bota M, Constantin AM, Pop LA, Maniu D, Crisan O, Cioban CV, Balacescu O, Coza O, Balacescu L, Marta MM, Dronca E, Cainap S. Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis, PLoS One. 2021 Apr 28;16(4):e0248922. doi: 10.1371/journal.pone.0248922 – 3.752
Cismaru Gabriel, Valean Iulia; Zirbo Mihnea Cantemir; Tirpe Alexandru; Cismaru Andrei; Rosu Radu; Puiu, Mihai; Muresan Lucian; Gusetu Gabriel; Minciuna Ioan-Alxandru; Florea Cristian Marius; Tomoaia Raluca; Zdrenghea Dumitru; Pop, Dana, Left Atrial Volume Correlates with Mitral Annulus Size: An MDCT Study. Applied Sciences-Basel. 2021, 11(23), 11329; https://doi.org/10.3390/app112311329 –2.838
Tamas T, Baciut M, Nutu A, Bran S, Armencea G, Stoia S, Manea A, Crisan L, Opris H, Onisor F, Baciut G, Crisan B, Opris D, Bumbu B, Tamas A, Dinu C., Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution? Genes (Basel). 2021 Nov 29;12(12):1929.- 4.141
Florian IA, Timis TL, Kiss KR, Florian IS, Berindan-Neagoe I. Ruptured pontine cavernomas in infants: a report of two cases.– Childs Nervous System, 2021 Mar;37(3):1009-1015. doi: 10.1007/s00381-020-04898-8 – 1.298
Cainap SS, Kovalenko I, Bonamano E, Crousen N, Tirpe A, Cismaru A, Iacob D, Lazea C, Negru A, Cismaru G., Anatomical-MRI Correlations in Adults and Children with Arrhythmogenic Right Ventricular Cardiomyopathy Diagnostics (Basel). Diagnostics (Basel). 2021 Jul 31;11(8):1388. doi: 10.3390/diagnostics11081388 – 3.992
Spînu Ș, Cismaru G, Boarescu PM, Istratoaie S, Negru AG, Lazea C, Căinap SS, Iacob D, Grosu AI, Saraci G, Burz C, Cismaru AC. ECG Markers of Cardiovascular Toxicity in Adult and Pediatric Cancer Treatment Disease Markers . 2021 Jan 19;2021:6653971. doi: 10.1155/2021/6653971 –3.464
ARTICOLE PUBLICATE 2020
Moloudizargari M, Asghari MH, Nabavi SF, Gulei D, Berindan-Neagoe I, Bishayee A, Nabavi SM. Targeting Hippo signaling pathway by phytochemicals in cancer therapy. Seminars In Cancer Biology, 2022 May;80:183-194. doi: 10.1016/j.semcancer.2020.05.005 17.012
Braicu C, Zanoaga O, Zimta AA, Tigu AB, Kilpatrick KL, Bishayee A, Nabavi SM, Berindan-Neagoe I. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells Seminars In Cancer Biology, 2022 May;80:218-236. doi: 10.1016/j.semcancer.2020.05.015. 17.012
Pirlog R, Piton N, Lamy A, Guisier F, Berindan-Neagoe I, Sabourin JC, Marguet F. Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas Cancers (Basel). 2022 Feb 17;14(4):1030. doi: 10.3390/cancers14041030 6.575
Dudea-Simon M, Mihu D, Pop LA, Ciortea R, Malutan AM, Diculescu D, Ciocan CA, Cojocneanu RM, Simon V, Bucuri C, Mocan-Hognogi R, Braicu C, Berindan-Neagoe I. Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer – International Journal Of Molecular Sciences, 2022 May 27;23(11):6054. doi: 10.3390/ijms23116054.6.208
Pirlog R, Chiroi P, Rusu I, Jurj AM, Budisan L, Pop-Bica C, Braicu C, Crisan D, Sabourin JC, Berindan-Neagoe I. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer, International Journal Of Molecular Sciences 2022 May 11;23(10):5346, doi: 10.3390/ijms23105346. 6.208
Pruteanu LL, Braicu C, Módos D, Jurj MA, Raduly LZ, Zănoagă O, Magdo L, Cojocneanu R, Paşca S, Moldovan C, Moldovan AI, Ţigu AB, Gurzău E, Jäntschi L, Bender A, Berindan-Neagoe I. Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines, International Journal Of Molecular Sciences 2022 Apr 26;23(9):4784. doi: 10.3390/ijms23094784. 6.208
Danku AE, Dulf EH, Braicu C, Jurj A, Berindan-Neagoe I; Organ-On-A-Chip: A Survey of Technical Results and Problems Frontiers In Bioengineering And Biotechnology, 2022 Feb 10;10:840674. doi: 10.3389/fbioe.2022.840674. eCollection 2022. PMID: 35223800 6.064
Lazar V, Raynaud J, Magidi S, Bresson C, Martini JF, Galbraith S, Wunder F, Onn A, Batist G, Girard N, Lassen U, Pramesh CS, Al-Omari A, Ikeda S, Berchem G, Blay JY, Solomon B, Felip E, Tabernero J, Rubin E, Philip T, Porgador A, Berindan-Neagoe I, Schilsky RL, Kurzrock R. – Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung Therapeutic Advances In Medical Oncology, 2022 Oct 28;14:17588359221133893. doi: 10.1177/17588359221133893 5.485
Ismaiel A, Spinu M, Socaciu C, Budisan L, Leucuta DC, Popa SL, Chis BA, Berindan-Neagoe I, Olinic DM, Dumitrascu DL. Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis Nutrition & Diabetes. 2022 Jan 18;12(1):4. doi: 10.1038/s41387-022-00182-7. PMID: 35042855 4.725
Pop-Bica C, Ciocan CA, Braicu C, Haranguș A, Simon M, Nutu A, Pop LA, Slaby O, Atanasov AG, Pirlog R, Al Hajjar N, Berindan-Neagoe I. Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes Journal Of Personalized Medicine, 2022, 12 (3), nr 453 3.508
Achimas-Cadariu P, Kubelac P, Irimie A, Berindan-Neagoe I, Rühli F Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present – Journal Of Ovarian Research, 2022 Jun 3;15(1):67, doi: 10.1186/s13048-022-01004-1 5.506
Aghiorghiesei O, Zanoaga O, Nutu A, Braicu C, Campian RS, Lucaciu O, Berindan Neagoe I. The World of Oral Cancer and Its Risk Factors Viewed from the Aspect of MicroRNA Expression Patterns. Genes (Basel). 2022 Mar 26;13(4):594. doi: 10.3390/genes13040594. PMID: 35456400 4.141
Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I. MicroRNA Dysregulation in Prostate Cancer, Pharmacogenomics & Personalized Medicine. 2022 Mar 10;15:177-193. doi: 10.2147/PGPM.S348565. eCollection 2022.PMID: 35300057 2.606
Vidra R, Ciuleanu TE, Nemeș A, Pascu O, Heroiu AM, Antone N, Vidrean AI, Oprean CM, Pop LA, Berindan-Neagoe I, Eniu R, Eniu A. Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients International Journal Of Environmental Research And Public Health. 2022 Apr 4;19(7):4314. doi: 10.3390/ijerph19074314.PMID: 35409996 4.614
Kasi Pandima Devi , Mahmoud Reza Pourkarim , Marijn Thijssen , Antoni Sureda Maryam Khayatkashani, Cosmin Andrei Cismaru , Ioana Berindan Neagoe , Solomon Habtemariam , Soha Razmjouei, Hamid Reza Khayat Kashani A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2, Pharmacological Reports, 2022, 2022 Apr;74(2):425-430. doi: 10.1007/s43440-021-00344-x 3.919
Domsa EM, Berindan-Neagoe I, Budisan L, Braicu C, Para I, Tantau AI, Orasan OH, Ciobanu L, Pop TA, Filip GA, Leach N, Negrean V, Matei D, Andreica V., Expression of Selected Genes and Circulating microRNAs in Patients with Celiac Disease, Medicina-Lithuania. 2022 Jan 25;58(2):180. doi: 10.3390/medicina58020180. 2.948
Ovidiu Aghiorghiesei, Oana Zanoaga, Lajos Raduly, Alexandra Iulia Aghiorghiesei, Paul Chiroi,Andrada Trif,Rares Buiga, Liviuta Budisan,Ondine Lucaciu, Laura Ancuta Pop,Cornelia Braicu,Radu Campian and Ioana Berindan-Neagoe – „Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?- Current Issues In Molecular Biology. 2022, 44(4), 1754-1767; https://doi.org/10.3390/cimb44040121 – 16 Apr 2022- 2.976
Constantin Busuioc, Rodica Daniela Birla, Flavia Ultimescu, Sorin Duţulescu, Eugenia Panaitescu, Ioana Berindan-Neagoe, Abberant Immunohistochemical Expression of OCT3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in Colorectal Adenocarcinoma, Chirurgia (Bucur) . 2022 Oct;117(5):544-555. doi: 10.21614/chirurgia.2782.0.26
Calvo-Lozano O, García-Aparicio P, Raduly LZ, Estévez MC, Berindan-Neagoe I, Ferracin M, Lechuga LM.- One-Step and Real-Time Detection of microRNA-21 in Human Samples for Lung Cancer Biosensing Diagnosis, Analytical Chemistry, OCT 2022, Volume 94, Issue 42, Page14659-14665, DOI10.1021/acs.analchem.2c02895 8.008
Jurj A, Ionescu C, Berindan-Neagoe I, Braicu C. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Journal Of Experimental & Clinical Cancer Research, SEP 16 2022, Volume 41, Issue 1, Article Number 276, DOI 10.1186/s13046-022-02484-1 12.658
Farc, O; Berindan-Neagoe, I; Zaharie, F; Budisan, L; Zanoaga, O; Cristea, V ,- A role for serum cytokines and cell adhesion molecules in the non-invasive diagnosis of colorectal cancer, Oncology Letters, SEP 2022, Volume 24, Issue 3, Article Number 323, DOI 10.3892/ol.2022.13443 3.111
Chira S, Nutu A, Isacescu E, Bica C, Pop L, Ciocan C, Berindan-Neagoe I. – Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research, Cells, SEP 2022, Volume 11, Issue 18, Article Number 2781, DOI 10.3390/cells11182781 7.666
Kacso TP, Zahu R, Tirpe A, Paslari EV, Nuțu A, Berindan-Neagoe I., Reactive Oxygen Species and Long Non-Coding RNAs, an Unexpected Crossroad in Cancer Cells, International Journal Of Molecular Sciences, SEP 2022, Volume 23 Issue 17, Article Number 10133, DOI 10.3390/ijms231710133 6.208
Cismaru CA, Pirlog R, Calin GA, Berindan-Neagoe I. – Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding, Stem Cell Reviews And Reports, DEC 2022, Volume 18, Issue 8, Page 2549-2565, DOI 10.1007/s12015-022-10428-7 6.692
Toma I, Porfire AS, Tefas LR, Berindan-Neagoe I, Tomuță I. – A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA Pharmaceutics, JUL 2022, Volume 14, Issue 7, Article Number 1482, DOI 10.3390/pharmaceutics14071482 6.525
Adrian-Alexandru Someșan, Sabina-Mădălina Vieriu, Alexandru Crăciun ,Cristian Silvestru, Paul Chiroi, Andreea Nutu, Ancuta Jurj, Raduly Lajos, Ioana Berindan-Neagoe, Richard A. Varga C , O ‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity Applied Organometallic Chemistry 2022, 36, e6540 . 4.072
Lazar V, Girard N, Raymond E, Martini JF, Galbraith S, Raynaud J, Bresson C, Solomon B, Magidi S, Nechushtan H, Onn A, Berger R, Chen H, Al-Omari A, Ikeda S, Lassen U, Sekacheva M, Felip E, Tabernero J, Batist G, Spatz A, Pramesh CS, Girard P, Blay JY, Philip T, Berindan-Neagoe I, Porgador A, Rubin E, Kurzrock R, Schilsky RL. Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies JCO Precision Oncology 2022 Sep;6:e2200072. doi: 10.1200/PO.22.00072. 5.479
Rusu I, Pirlog R, Chiroi P, Nutu A, Puia VR, Fetti AC, Rusu DR, Berindan-Neagoe I, Al Hajjar N.- The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC International Journal Of Molecular Sciences, 2022 Oct15;23(20):12370. doi: 10.3390/ijms232012370. 6.208
Neamtiu IA, Surcel M, Begum TF, Gurzau ES, Berindan-Neagoe I, Braicu C, Rotar I, Muresan D, Bloom MS. Specific lifestyle factors and in vitro fertilization outcomes in Romanian women: a pilot study Peer J. 2022 Oct 4;10:e14189. doi: 10.7717/peerj.14189. eCollection 2022. 3.061
Cismaru CA, Chira S, Cismaru GL, Nutu AM, Netea MG, Berindan-Neagoe I. Assessment of the frequency of coughing and sneezing triggered by nasopharyngeal swabbing in the pandemic setting – Scientific Reports, 2022 Jun 27;12(1):10874. doi: 10.1038/s41598-022-14755-0. 4.997
Burghelea D, Moisoiu T, Ivan C, Elec A, Munteanu A, Iancu ȘD, Truta A, Kacso TP, Antal O, Socaciu C, Elec FI, Kacso IM.The Use of Machine Learning Algorithms and the Mass Spectrometry Lipidomic Profile of Serum for the Evaluation of Tacrolimus Exposure and Toxicity in Kidney Transplant Recipients. Biomedicines. 2022 May 17;10(5):1157. doi: 10.3390/biomedicines10051157.PMID: 35625894 4.757
Stefancu A, Moisoiu V, Desmirean M, Iancu SD, Tigu AB, Petrushev B, Jurj A, Cozan RG, Budisan L, Fetica B, Roman A, Dobie G, Turcas C, Zdrenghea M, Teodorescu P, Pasca S, Piciu D, Dima D, Bálint Z, Leopold N, Tomuleasa CSERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathy.. Spectrochimica Acta Part A-Molecular And Biomolecular Spectroscopy. 2022 Jan 5;264:120216. doi: 10.1016/j.saa.2021.120216. Epub 2021 Jul 21. 4.831
Ticala M, Rusu CC, Moldovan D, Potra AR, Tirinescu DC, Coman AL, Bondor CI, Budisan L, Kacsó IM Hemodialysis Patients with Higher Serum Levels of Soluble Receptor for Advanced Glycation End Products Have an Increased Risk for Arteriovenous Fistula Failure.. Blood Purification. 2022;51(9):764-771. doi: 10.1159/000519879. Epub 2021 Nov 18. PMID: 34794141 3.348
Ticala M, Rusu CC, Moldovan D, Potra AR, Tirinescu DC, Coman AL, Bondor CI, Budisan L, Kacso IM Relationship between vascular cell adhesion molecule-1 (VCAM-1), soluble receptor for advanced glycation end products (sRAGE) and functional hemodynamic parameters of arteriovenous fistula. Journal Of Vascular Access. 2022 Jan;23(1):67-74. doi: 10.1177/1129729820976264. 2.326
Rosu RO, Lupsor A, Necula A, Cismaru G, Cainap SS, Iacob D, Lazea C, Cismaru A, Negru AG, Pop D, Gusetu G. Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.Diagnostics (Basel). 2022 Feb 14;12(2):489. doi: 10.3390/diagnostics12020489.PMID: 35204578 3.992
Ilut S, Pirlog BO, Pirlog R, Nutu A, Vacaras V, Armean SM Recent Advances on the Roles of PCSK-9 Inhibitors in the Management of Acute Ischemic Stroke Patients. International Journal of Molecular Sciences. 2022 Sep 6;23(18):10221. doi: 10.3390/ijms231810221.PMID: 36142135. 6.208
Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, Pop LA Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis..Front Microbiol. 2022 Jun 20; 13:908525. doi: 10.3389/fmicb.2022.908525. eCollection 2022.PMID: 35794916. 6.064
Faur, C.I.; Roman, R.C.; Jurj, A.; Raduly, L.; Almășan, O.; Rotaru, H.; Chirilă, M.; Moldovan, M.A.; Hedeșiu, M.; Dinu, C.. Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma Medicina 2022, 58, 1478. https://doi.org/10.3390/medicina58101478 2.948
Cosmin Andrei Cismaru, Radu Pirlog, George Adrian Calin, Ioana Berindan‑Neagoe. Stem Cells in the Tumor Immune Microenvironment –Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding. Stem Cell Reviews and Reports (2022) 18:2549–2565. https://doi.org/10.1007/s12015-022-10428-7 6,692
Haranguș A, Lajos R, Budisan L, Zanoaga O, Ciocan C, Bica C, Pirlog R, Simon I, Simon M, Braicu C, Berindan-Neagoe I. Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods. J Pers Med. 2022 Dec 13;12(12):2056. doi: 10.3390/jpm12122056. PMID: 36556276; PMCID: PMC9780989.
Mehterov N, Sacconi A, Pulito C, Vladimirov B, Haralanov G, Pazardjikliev D, Nonchev B, Berindan-Neagoe I, Blandino G, Sarafian V. A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa. Front Oncol. 2022 Dec 1; 12:1072579. doi: 10.3389/fonc.2022.1072579. PMID: 36531016; PMCID: PMC9753689.
Antoniraj MG, Devi KP, Berindan-Neagoe I, Nabavi SF, Kashani HRK, Aghaabdollahian S, Afkhami F, Jeandet P, Lorigooini Z, Khayatkashani M, Nabavi SM. Oral microbiota in cancer: Could the bad guy turn good with application of polyphenols? Expert Rev Mol Med. 2022 Dec 13:1-63. doi: 10.1017/erm.2022.39. Epub ahead of print. PMID: 36511134.
ARTICOLE PUBLICATE 2019
Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I. Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes. Cells. 2019 Jan 8;8(1). pii: E29. doi: 10.3390/cells8010029-4.36
Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S. Targeting Hedgehog signaling pathway: paving the road for cancer therapy. Pharmacological Research. 2019 Jan 10. pii: S1043-6618(18)30855-7. doi:10.1016/j.phrs.2019.01.014.-5.893
Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. miR-181a/b therapy in lung cancer: reality or myth? Molecular Oncology. 2019 Jan 13(1):9-25-6.574
Zimta AA, Baru O, Badea M, Buduru SD, Berindan-Neagoe I. The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry. International Journal Of Molecular Sciences. 2019 Jan 18;20(2). pii: E406. doi: 10.3390/ijms20020406.- 4.556
Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.CRISPR-based RNA editing: diagnostic applications and therapeutic options. Expert Review of Molecular Diagnostics. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242.- 4.096
Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, Pop L, Raduly L, Barbat A, Moldovan A, Moldovan C, Tigu AB, Ionescu C, Atanasov AG, Irimie A, Berindan-Neagoe I. Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies. International Journal of Molecular Sciences. 2019 Mar 9;20(5). pii: E1199. –4.556
Braicu C , Zimta AA, Gulei D; Olariu A, Berindan-Neagoe I. Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance. Cellular and Molecular Life Sciences. 2019 Apr;76(8):1559-1577. doi: 10.1007/s00018-019-03016-5. – 6.496
Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S. Novel therapeutic strategies for stroke: The role of autophagy. Critical Reviews in Clinical Laboratory Sciences, 2019 Mar 1:1-18.-4.677
Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR.Use of flow cytometry in the phenotypic diagnosis of hodgkin’s lymphoma. Cytometry Part B-Clinical Cytometry. 2019 Mar;96(2):116-127. doi: 10.1002/cyto.b.21724. Epub 2018 Oct 22- 2.93
Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I Mesenchymal stem cells in myeloproliferative disorders – focus on primary myelofibrosis. Leukemia & Lymphoma. 2019 Apr;60(4):876-885. doi: 10.1080/10428194.2018.1516881-2.674
Tripon, RE; Neagoe, IB; Budisan, L ; Pop, TL; Cristea, V; Stanca, LM ; Lupse, MS. Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes. Revista Romana De Medicina De Laborator. APR 2019. Volume: 27.Issue: 2.Pages: 189-198.DOI: 10.2478/rrlm-2019-0020 –0.8
Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall’Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG. Curcumin: Total-Scale Analysis of the Scientific Literature. Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393- 3.06
Braicu C, Zimta AA, Harangus A, Iurca I, Irimie A, Coza O, Berindan-Neagoe I. The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis. Cancers (Basel). 2019 Apr 30;11(5). pii: E605. doi: 10.3390/cancers11050605- 6.162
Sas V, Blag C, Zaharie G, Puscas E, Lisencu C, Andronic-Gorcea N, Pasca S, Petrushev B, Chis I, Marian M, Dima D, Teodorescu P, Iluta S, Zdrenghea M, Berindan-Neagoe I, Popa G, Man S, Colita A, Stefan C, Kojima S, Tomuleasa C. Transient leukemia of Down Syndrome. Critical Reviews in Clinical Laboratory Sciences.2019 May 1:1-37.doi:10.1080/10408363.2019.1613629.-4.677
Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I. Gold nanorods: from anisotropy to opportunity. An evolution update. Nanomedicine (Lond). 2019 14(9):1203-1226: 10.2217/nnm-2018-0409 – 4.717
Cismaru CA, Soritau O, Jurj AM, Lajos R, Pop B, Bocean C, Albzour B, Baldasici O, Moldovan C, Neagoe IB.Isolation and Characterization of a Fetal-Maternal Microchimeric Stem Cell Population in Maternal Hair Follicles Long after Parturition. Stem Cell Reviews and Reports. 2019 15(4):519-529. doi: 10.1007/s12015-019-09885-4. –.697
Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, Cojocneanu R, Pruteanu LL, Iuga CA, Coza O, Berindan-Neagoe I. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer „Omics”. International Journal of Molecular Sciences. 2019 May 25;20(10). pii: E2576. doi: 10.3390/ijms20102576.-4.556
Constantinescu C, Bodolea C, Pasca S, Teodorescu P, Dima D, Rus I, Tat T, Achimas-Cadariu P, Tanase A, Tomuleasa C, Einsele H. Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician. Journal Of Clinical Medicine. 2019 Jun; 8(6): 884. Published online 2019 Jun 20. doi: 10.3390/jcm8060884-5.688
Irimie AI, Braicu C, Pasca S, Magdo L, Gulei D, Cojocneanu R, Ciocan C, Olariu A, Coza O, Berindan-Neagoe I. Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention. Medicina (Kaunas). 2019 Jun 18;55(6). pii: E283. doi: 10.3390/medicina55060283-1.467
Paradiso AV, Patruno M, De Summa S, Tommasi S, Berindan-Neagoe I. BRCA germline mutation test for all woman with ovarian cancer? BMC Cancer, JUN 28 2019, Volume: 19, Article Number: 641, DOI: 10.1186/s12885-019-5829-4-2.933
Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, Gargaro M, Manni G, Pirro M, Xu S, Sadeghi M, Nabavi SF, Shirooie S. Toll-like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048.-3.702
Gulei D, Berindan-Neagoe I. Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9. Molecular Therapy: Nucleic Acids. 2019 Jul 3;17:448-451. doi: 10.1016/j.omtn.2019.05.032. –5.919
Bagacean C, Tomuleasa C, Tempescul A, Grewal R, Brooks WH, Berthou C, Renaudineau Y. Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives. Critical Reviews In Clinical Laboratory Sciences. 2019,Volume: 56. Pages: 321-332.DOI: 10.1080/10408363.2019.1600468 – 4.677
Kubelac, P ; Vlad, C; Berindan-Neagoe, I; Irimie, A; Achimas-Cadariu, P. The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients. Journal of BUON. 2019 Jul-Aug;24(4):1538-1543.-1.379
Sas V, Moisoiu V, Teodorescu P, Tranca S, Pop L, Iluta S, Pasca S, Blag C, Man S, Roman A, Constantinescu C, Rus I, Buse M, Fetica B, Marian M, Selicean C, Berindan-Neagoe I, Petrushev B, Bumbea H, Tanase A, Zdrenghea M, Fuji S, Kitano S, Tomuleasa C. Approach to the Adult Acute Lymphoblastic Leukemia Patient. Journal of Clinical Medicine. 2019 Aug 6;8(8). pii: E1175. doi: 10.3390/jcm8081175.-5.688
Colceriu-Șimon IM, Hedeșiu M, Toma V, Armencea G, Moldovan A, Știufiuc G, Culic B, Țărmure V, Dinu C, Berindan-Neagoe I, Știufiuc RI, Băciuț M. The Effects of Low-Dose Irradiation on Human Saliva: A Surface-Enhanced Raman Spectroscopy Study, Diagnostics (Basel). 2019 Aug 22;9(3). pii: E101. doi: 10.3390/diagnostics9030101.-2.489
Moloudizargari M, Abdollahi M, Asghari MH, Zimta AA, Neagoe IB, Nabavi SM. The emerging role of exosomes in multiple myeloma. Blood Reviews. 2019 Aug 8:100595. doi: 10.1016/j.blre.2019.100595. 6.125
Moisoiu V, Stefancu A, Gulei D, Boitor R, Magdo L, Raduly L, Pasca S, Kubelac P, Mehterov N, Chiș V, Simon M, Muresan M, Irimie A, Baciut M, Stiufiuc R, Pavel IE, Achimas-Cadariu P, Ionescu C, Lazar V, Sarafian V, Notingher I, Leopold N, Berindan-Neagoe I. SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer. International Journal of Nanomedicine. 2019 Aug 2;14:6165-6178. doi: 10.2147/IJN.S198684. – 4.471
Onaciu A, Munteanu RA, Moldovan AI, Moldovan CS, Berindan-Neagoe I. Hydrogels Based Drug Delivery Synthesis, Characterization and administration. Pharmaceutics. 2019 Aug 23;11(9). pii: E432. doi:0.3390/pharmaceutics 11090432.- 4.773
Saftencu M, Braicu C, Cojocneanu R, Buse M, Irimie A, Piciu D, Berindan-Neagoe I, Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer. Medicina (Kaunas). 2019 Aug 19;55(8). pii: E500. doi: 10.3390/medicina55080500- 1.467
Tatar AS, Jurj A, Tomuleasa C, Florea A, Berindan-Neagoe I, Cialla-May D, Popp J, Astilean S, Boca S. CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia. Colloids and Surfaces B: Biointerfaces. 2019 Aug 30;184:110478. doi: 10.1016/j.colsurfb.2019.110478. –3.973
Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga R, Berindan-Neagoe I. Progress in Research on the Role of Flavonoids in Lung Cancer. International Journal Of Molecular Sciences. 2019 Sep 2;20(17). pii: E4291-4.556
Colita, A ; Colita, A; Bumbea H ; Croitoru, A; Orban C; Lipan LE; Craciun, OG ; Soare, D; Ghimici, C ; Manolache, R ; Gelatu, I; Vladareanu, AM; Pasca, S ; Teodorescu, P ; Dima, D ; Lupu, A ; Coriu, D ; Tomuleasa, C; Tanase, A. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation – Frontiers In Oncology, 2019 Sep 10;9:892. doi: 10.3389/fonc.2019.00892. eCollection 2019-4.137
Dobrowolski J, Pasca S, Teodorescu P, Selicean C, Rus I, Zdrenghea M, Bojan A, Trifa A, Fetica B, Petrushev B, Rosu AM, Berindan-Neagoe I, Tomuleasa C, Dima D. Persistent Basophilia May Suggest an „Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia. Frontiers In Oncology 2019 Sep 6;9:872. doi: 10.3389/fonc.2019.00872. eCollection 2019-4.137
Gulei D, Raduly L, Broseghini E, Ferracin M, Berindan-Neagoe I. The extensive role of miR-155 in malignant and non-malignant diseases. Molecular aspects of medicine. 2019 Sep 23. pii: S0098-2997(19)30080-9-8.313
Moisoiu V, Teodorescu P, Parajdi L, Pasca S, Zdrenghea M, Dima D, Precup R, Tomuleasa C, Soverini S. Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology. Frontiers in Oncology. 2019 Sep 23;9:863. doi: 10.3389/fonc.2019.00863. eCollection 2019-4.137
Farcas M, Gavrea AA, Gulei D, Ionescu C, Irimie A, Catana CS, Berindan-Neagoe I. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition. 2019 Sep 25;6:148. doi: 10.3389/fnut.2019.00148. eCollection 2019.- 0
Zimta A, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe I. Long Non-coding RNAs in Myeloid Malignancies. Frontiers in Oncology. 2019 Oct 18;9:1048. doi: 10.3389/fonc.2019.01048. eCollection 2019- 4.137
Deak D, Pop C, Zimta AA, Jurj A, Ghiaur A, Pasca S, Teodorescu P, Dascalescu A, Antohe I, Ionescu B, Constantinescu C, Onaciu A, Munteanu R, Berindan-Neagoe I, Petrushev B, Turcas C, Iluta S, Selicean C, Zdrenghea M, Tanase A, Danaila C, Colita A, Colita A, Dima D, Coriu D, Einsele H, Tomuleasa C. Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology. 2019 Dec 20;10:2856. doi: 10.3389/fimmu.2019.02856. eCollection 2019- 4.716
Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie, Atanasov AG Slaby O, Ionescu C, Berindan-Neagoe I16,17,18. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel). 2019 Oct 22;11(10). pii: E1618. doi: 10.3390/cancers11101618.- 6.162
Pasca S, Tomuleasa C, Teodorescu P, Ghiaur G, Dima D, Moisoiu V, Berce C, Stefan C, Ciechanover A, Einsele H. KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma. Frontiers in Oncology. 2019 Oct 24;9:1137. doi: 10.3389/fonc.2019.01137. eCollection 2019- 4,416
Zimta AA, Tigu AB, Muntean M, Cenariu D, Slaby O, Berindan-Neagoe I. Molecular Links between Central Obesity and Breast Cancer. International Journal of Molecular Sciences. 2019 Oct 28;20(21). pii: E5364. doi: 10.3390/ijms20215364 – 4.556
Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, Chira S, Budisan L, Jurj A, Ciocan C, Magdo L, Irimie A, Dobrota F, Petrut B, Berindan-Neagoe I. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. Journal of Experimental & Clinical Cancer Research. 2019 Oct 29;38(1):433. doi: 10.1186/s13046-019-1406-6.- 5.646
Zimta AA, Schitcu V, Gurzau E, Stavaru C, Manda G, Szedlacsek S, Berindan-Neagoe I. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development. Environmental Research. 2019 Nov;178:108700. doi: 10.1016/j.envres.2019.108700. Epub 2019 Aug 28.-5.026
Zaharie F, Pop LA, Petrushev B, Jurj A, Muresan MS, Eniu D, Fetica B, Petkov B, Pasca S, Piciu D, Rus I, Deak D, Dima D, Desmirean MS, Tomuleasa C, Berindan-Neagoe I. Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient. Histology and Histopathology. 2019 Nov 23:18067-1.777
Marin DE, Braicu C, Dumitrescu G, Pistol GC, Cojocneanu R, Neagoe IB, Taranu I. MicroRNA profiling in kidney in pigs fed ochratoxin A contaminated diet. Ecotoxicology and Environmental Safety. 2019 Nov 30;184:109637. doi: 10.1016/j.ecoenv.2019.109637 –4.527
Braicu C, Gulei D, Raduly L, Harangus A, Rusu A, Berindan-Neagoe I. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms. Molecular Aspects of Medicine. 2019 Nov 5. pii: S0098-2997(19)30062-7. doi: 10.1016/j.mam.2019.10.007 –8.313
Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I. The Role of Nrf2 Activity in Cancer Development and Progression. Cancers (Basel). 2019 Nov 8;11(11). pii: E1755. doi: 10.3390/cancers11111755- 6.162
Šudomová M, Shariati MA, Echeverría J, Berindan-Neagoe I, Nabavi SM, Hassan STS.A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Marine Drugs. 2019 Nov 14;17(11). pii: E641. doi: 10.3390/md17110641-3.772
Moisoiu V, Stefancu A, Iancu SD, Moisoiu T, Loga L, Dican L, Alecsa CD, Boros I, Jurj A, Dima D, Bagacean C, Tetean R, Burzo E, Tomuleasa C, Elec F, Leopold N. SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation.Analytical and Bioanalytical Chemistry. 2019 Nov;411(29):7907-7913. doi: 10.1007/s00216-019-02213-2. Epub 2019 Nov 20- 3.286
Irimie-Aghiorghiesei AI, Pop-Bica C, Pintea S, Braicu C, Cojocneanu R, Zimța AA, Gulei D, Slabý O, Berindan-Neagoe I. Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC). Journal of Clinical Medicine. 2019 Nov 21;8(12). pii: E2041. doi: 10.3390/jcm8122041- 5.688
Tirpe AA, Gulei D, Ciortea SM, Crivii C, Berindan-Neagoe I. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. International Journal of Molecular Sciences. 2019 Dec 5;20(24). pii: E6140. doi: 10.3390/ijms20246140 –4.55
Haranguș A, Berindan-Neagoe I, Todea DA, Șimon I, Șimon M. Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review. Diagnostics (Basel). 2019 Dec 9;9(4). pii: E216. doi: 10.3390/diagnostics9040216- 2.489
Tat T, Jurj A, Selicean C, Pasca S, Ionescu D. Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment. Journal Of Buon. 2019 Jan-Feb;24(1):106-115. PubMed PMID: 30941958 – 1.695
ARTICOLE PUBLICATE 2018
Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I. Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes. Cells. 2019 Jan 8;8(1). pii: E29. doi: 10.3390/cells8010029-4.36
Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S. Targeting Hedgehog signaling pathway: paving the road for cancer therapy. Pharmacological Research. 2019 Jan 10. pii: S1043-6618(18)30855-7. doi:10.1016/j.phrs.2019.01.014.-5.893
Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. miR-181a/b therapy in lung cancer: reality or myth? Molecular Oncology. 2019 Jan 13(1):9-25-6.574
Zimta AA, Baru O, Badea M, Buduru SD, Berindan-Neagoe I. The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry. International Journal Of Molecular Sciences. 2019 Jan 18;20(2). pii: E406. doi: 10.3390/ijms20020406.- 4.556
Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.CRISPR-based RNA editing: diagnostic applications and therapeutic options. Expert Review of Molecular Diagnostics. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242.- 4.096
Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, Pop L, Raduly L, Barbat A, Moldovan A, Moldovan C, Tigu AB, Ionescu C, Atanasov AG, Irimie A, Berindan-Neagoe I. Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies. International Journal of Molecular Sciences. 2019 Mar 9;20(5). pii: E1199. –4.556
Braicu C , Zimta AA, Gulei D; Olariu A, Berindan-Neagoe I. Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance. Cellular and Molecular Life Sciences. 2019 Apr;76(8):1559-1577. doi: 10.1007/s00018-019-03016-5. – 6.496
Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S. Novel therapeutic strategies for stroke: The role of autophagy. Critical Reviews in Clinical Laboratory Sciences, 2019 Mar 1:1-18.-4.677
Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR.Use of flow cytometry in the phenotypic diagnosis of hodgkin’s lymphoma. Cytometry Part B-Clinical Cytometry. 2019 Mar;96(2):116-127. doi: 10.1002/cyto.b.21724. Epub 2018 Oct 22- 2.93
Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I Mesenchymal stem cells in myeloproliferative disorders – focus on primary myelofibrosis. Leukemia & Lymphoma. 2019 Apr;60(4):876-885. doi: 10.1080/10428194.2018.1516881-2.674
Tripon, RE; Neagoe, IB; Budisan, L ; Pop, TL; Cristea, V; Stanca, LM ; Lupse, MS. Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes. Revista Romana De Medicina De Laborator. APR 2019. Volume: 27.Issue: 2.Pages: 189-198.DOI: 10.2478/rrlm-2019-0020 –0.8
Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall’Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG. Curcumin: Total-Scale Analysis of the Scientific Literature. Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393- 3.06
Braicu C, Zimta AA, Harangus A, Iurca I, Irimie A, Coza O, Berindan-Neagoe I. The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis. Cancers (Basel). 2019 Apr 30;11(5). pii: E605. doi: 10.3390/cancers11050605- 6.162
Sas V, Blag C, Zaharie G, Puscas E, Lisencu C, Andronic-Gorcea N, Pasca S, Petrushev B, Chis I, Marian M, Dima D, Teodorescu P, Iluta S, Zdrenghea M, Berindan-Neagoe I, Popa G, Man S, Colita A, Stefan C, Kojima S, Tomuleasa C. Transient leukemia of Down Syndrome. Critical Reviews in Clinical Laboratory Sciences.2019 May 1:1-37.doi:10.1080/10408363.2019.1613629.-4.677
Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I. Gold nanorods: from anisotropy to opportunity. An evolution update. Nanomedicine (Lond). 2019 14(9):1203-1226: 10.2217/nnm-2018-0409 – 4.717
Cismaru CA, Soritau O, Jurj AM, Lajos R, Pop B, Bocean C, Albzour B, Baldasici O, Moldovan C, Neagoe IB.Isolation and Characterization of a Fetal-Maternal Microchimeric Stem Cell Population in Maternal Hair Follicles Long after Parturition. Stem Cell Reviews and Reports. 2019 15(4):519-529. doi: 10.1007/s12015-019-09885-4. –.697
Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, Cojocneanu R, Pruteanu LL, Iuga CA, Coza O, Berindan-Neagoe I. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer „Omics”. International Journal of Molecular Sciences. 2019 May 25;20(10). pii: E2576. doi: 10.3390/ijms20102576.-4.556
Constantinescu C, Bodolea C, Pasca S, Teodorescu P, Dima D, Rus I, Tat T, Achimas-Cadariu P, Tanase A, Tomuleasa C, Einsele H. Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician. Journal Of Clinical Medicine. 2019 Jun; 8(6): 884. Published online 2019 Jun 20. doi: 10.3390/jcm8060884-5.688
Irimie AI, Braicu C, Pasca S, Magdo L, Gulei D, Cojocneanu R, Ciocan C, Olariu A, Coza O, Berindan-Neagoe I. Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention. Medicina (Kaunas). 2019 Jun 18;55(6). pii: E283. doi: 10.3390/medicina55060283-1.467
Paradiso AV, Patruno M, De Summa S, Tommasi S, Berindan-Neagoe I. BRCA germline mutation test for all woman with ovarian cancer? BMC Cancer, JUN 28 2019, Volume: 19, Article Number: 641, DOI: 10.1186/s12885-019-5829-4-2.933
Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, Gargaro M, Manni G, Pirro M, Xu S, Sadeghi M, Nabavi SF, Shirooie S. Toll-like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048.-3.702
Gulei D, Berindan-Neagoe I. Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9. Molecular Therapy: Nucleic Acids. 2019 Jul 3;17:448-451. doi: 10.1016/j.omtn.2019.05.032. –5.919
Bagacean C, Tomuleasa C, Tempescul A, Grewal R, Brooks WH, Berthou C, Renaudineau Y. Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives. Critical Reviews In Clinical Laboratory Sciences. 2019,Volume: 56. Pages: 321-332.DOI: 10.1080/10408363.2019.1600468 – 4.677
Kubelac, P ; Vlad, C; Berindan-Neagoe, I; Irimie, A; Achimas-Cadariu, P. The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients. Journal of BUON. 2019 Jul-Aug;24(4):1538-1543.-1.379
Sas V, Moisoiu V, Teodorescu P, Tranca S, Pop L, Iluta S, Pasca S, Blag C, Man S, Roman A, Constantinescu C, Rus I, Buse M, Fetica B, Marian M, Selicean C, Berindan-Neagoe I, Petrushev B, Bumbea H, Tanase A, Zdrenghea M, Fuji S, Kitano S, Tomuleasa C. Approach to the Adult Acute Lymphoblastic Leukemia Patient. Journal of Clinical Medicine. 2019 Aug 6;8(8). pii: E1175. doi: 10.3390/jcm8081175.-5.688
Colceriu-Șimon IM, Hedeșiu M, Toma V, Armencea G, Moldovan A, Știufiuc G, Culic B, Țărmure V, Dinu C, Berindan-Neagoe I, Știufiuc RI, Băciuț M. The Effects of Low-Dose Irradiation on Human Saliva: A Surface-Enhanced Raman Spectroscopy Study, Diagnostics (Basel). 2019 Aug 22;9(3). pii: E101. doi: 10.3390/diagnostics9030101.-2.489
Moloudizargari M, Abdollahi M, Asghari MH, Zimta AA, Neagoe IB, Nabavi SM. The emerging role of exosomes in multiple myeloma. Blood Reviews. 2019 Aug 8:100595. doi: 10.1016/j.blre.2019.100595. 6.125
Moisoiu V, Stefancu A, Gulei D, Boitor R, Magdo L, Raduly L, Pasca S, Kubelac P, Mehterov N, Chiș V, Simon M, Muresan M, Irimie A, Baciut M, Stiufiuc R, Pavel IE, Achimas-Cadariu P, Ionescu C, Lazar V, Sarafian V, Notingher I, Leopold N, Berindan-Neagoe I. SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer. International Journal of Nanomedicine. 2019 Aug 2;14:6165-6178. doi: 10.2147/IJN.S198684. – 4.471
Onaciu A, Munteanu RA, Moldovan AI, Moldovan CS, Berindan-Neagoe I. Hydrogels Based Drug Delivery Synthesis, Characterization and administration. Pharmaceutics. 2019 Aug 23;11(9). pii: E432. doi:0.3390/pharmaceutics 11090432.- 4.773
Saftencu M, Braicu C, Cojocneanu R, Buse M, Irimie A, Piciu D, Berindan-Neagoe I, Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer. Medicina (Kaunas). 2019 Aug 19;55(8). pii: E500. doi: 10.3390/medicina55080500- 1.467
Tatar AS, Jurj A, Tomuleasa C, Florea A, Berindan-Neagoe I, Cialla-May D, Popp J, Astilean S, Boca S. CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia. Colloids and Surfaces B: Biointerfaces. 2019 Aug 30;184:110478. doi: 10.1016/j.colsurfb.2019.110478. –3.973
Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga R, Berindan-Neagoe I. Progress in Research on the Role of Flavonoids in Lung Cancer. International Journal Of Molecular Sciences. 2019 Sep 2;20(17). pii: E4291-4.556
Colita, A ; Colita, A; Bumbea H ; Croitoru, A; Orban C; Lipan LE; Craciun, OG ; Soare, D; Ghimici, C ; Manolache, R ; Gelatu, I; Vladareanu, AM; Pasca, S ; Teodorescu, P ; Dima, D ; Lupu, A ; Coriu, D ; Tomuleasa, C; Tanase, A. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation – Frontiers In Oncology, 2019 Sep 10;9:892. doi: 10.3389/fonc.2019.00892. eCollection 2019-4.137
Dobrowolski J, Pasca S, Teodorescu P, Selicean C, Rus I, Zdrenghea M, Bojan A, Trifa A, Fetica B, Petrushev B, Rosu AM, Berindan-Neagoe I, Tomuleasa C, Dima D. Persistent Basophilia May Suggest an „Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia. Frontiers In Oncology 2019 Sep 6;9:872. doi: 10.3389/fonc.2019.00872. eCollection 2019-4.137
Gulei D, Raduly L, Broseghini E, Ferracin M, Berindan-Neagoe I. The extensive role of miR-155 in malignant and non-malignant diseases. Molecular aspects of medicine. 2019 Sep 23. pii: S0098-2997(19)30080-9-8.313
Moisoiu V, Teodorescu P, Parajdi L, Pasca S, Zdrenghea M, Dima D, Precup R, Tomuleasa C, Soverini S. Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology. Frontiers in Oncology. 2019 Sep 23;9:863. doi: 10.3389/fonc.2019.00863. eCollection 2019-4.137
Farcas M, Gavrea AA, Gulei D, Ionescu C, Irimie A, Catana CS, Berindan-Neagoe I. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition. 2019 Sep 25;6:148. doi: 10.3389/fnut.2019.00148. eCollection 2019.- 0
Zimta A, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe I. Long Non-coding RNAs in Myeloid Malignancies. Frontiers in Oncology. 2019 Oct 18;9:1048. doi: 10.3389/fonc.2019.01048. eCollection 2019- 4.137
Deak D, Pop C, Zimta AA, Jurj A, Ghiaur A, Pasca S, Teodorescu P, Dascalescu A, Antohe I, Ionescu B, Constantinescu C, Onaciu A, Munteanu R, Berindan-Neagoe I, Petrushev B, Turcas C, Iluta S, Selicean C, Zdrenghea M, Tanase A, Danaila C, Colita A, Colita A, Dima D, Coriu D, Einsele H, Tomuleasa C. Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology. 2019 Dec 20;10:2856. doi: 10.3389/fimmu.2019.02856. eCollection 2019- 4.716
Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie, Atanasov AG Slaby O, Ionescu C, Berindan-Neagoe I16,17,18. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel). 2019 Oct 22;11(10). pii: E1618. doi: 10.3390/cancers11101618.- 6.162
Pasca S, Tomuleasa C, Teodorescu P, Ghiaur G, Dima D, Moisoiu V, Berce C, Stefan C, Ciechanover A, Einsele H. KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma. Frontiers in Oncology. 2019 Oct 24;9:1137. doi: 10.3389/fonc.2019.01137. eCollection 2019- 4,416
Zimta AA, Tigu AB, Muntean M, Cenariu D, Slaby O, Berindan-Neagoe I. Molecular Links between Central Obesity and Breast Cancer. International Journal of Molecular Sciences. 2019 Oct 28;20(21). pii: E5364. doi: 10.3390/ijms20215364 – 4.556
Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, Chira S, Budisan L, Jurj A, Ciocan C, Magdo L, Irimie A, Dobrota F, Petrut B, Berindan-Neagoe I. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. Journal of Experimental & Clinical Cancer Research. 2019 Oct 29;38(1):433. doi: 10.1186/s13046-019-1406-6.- 5.646
Zimta AA, Schitcu V, Gurzau E, Stavaru C, Manda G, Szedlacsek S, Berindan-Neagoe I. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development. Environmental Research. 2019 Nov;178:108700. doi: 10.1016/j.envres.2019.108700. Epub 2019 Aug 28.-5.026
Zaharie F, Pop LA, Petrushev B, Jurj A, Muresan MS, Eniu D, Fetica B, Petkov B, Pasca S, Piciu D, Rus I, Deak D, Dima D, Desmirean MS, Tomuleasa C, Berindan-Neagoe I. Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient. Histology and Histopathology. 2019 Nov 23:18067-1.777
Marin DE, Braicu C, Dumitrescu G, Pistol GC, Cojocneanu R, Neagoe IB, Taranu I. MicroRNA profiling in kidney in pigs fed ochratoxin A contaminated diet. Ecotoxicology and Environmental Safety. 2019 Nov 30;184:109637. doi: 10.1016/j.ecoenv.2019.109637 –4.527
Braicu C, Gulei D, Raduly L, Harangus A, Rusu A, Berindan-Neagoe I. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms. Molecular Aspects of Medicine. 2019 Nov 5. pii: S0098-2997(19)30062-7. doi: 10.1016/j.mam.2019.10.007 –8.313
Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I. The Role of Nrf2 Activity in Cancer Development and Progression. Cancers (Basel). 2019 Nov 8;11(11). pii: E1755. doi: 10.3390/cancers11111755- 6.162
Šudomová M, Shariati MA, Echeverría J, Berindan-Neagoe I, Nabavi SM, Hassan STS.A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Marine Drugs. 2019 Nov 14;17(11). pii: E641. doi: 10.3390/md17110641-3.772
Moisoiu V, Stefancu A, Iancu SD, Moisoiu T, Loga L, Dican L, Alecsa CD, Boros I, Jurj A, Dima D, Bagacean C, Tetean R, Burzo E, Tomuleasa C, Elec F, Leopold N. SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation.Analytical and Bioanalytical Chemistry. 2019 Nov;411(29):7907-7913. doi: 10.1007/s00216-019-02213-2. Epub 2019 Nov 20- 3.286
Irimie-Aghiorghiesei AI, Pop-Bica C, Pintea S, Braicu C, Cojocneanu R, Zimța AA, Gulei D, Slabý O, Berindan-Neagoe I. Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC). Journal of Clinical Medicine. 2019 Nov 21;8(12). pii: E2041. doi: 10.3390/jcm8122041- 5.688
Tirpe AA, Gulei D, Ciortea SM, Crivii C, Berindan-Neagoe I. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. International Journal of Molecular Sciences. 2019 Dec 5;20(24). pii: E6140. doi: 10.3390/ijms20246140 –4.55
Haranguș A, Berindan-Neagoe I, Todea DA, Șimon I, Șimon M. Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review. Diagnostics (Basel). 2019 Dec 9;9(4). pii: E216. doi: 10.3390/diagnostics9040216- 2.489
Tat T, Jurj A, Selicean C, Pasca S, Ionescu D. Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment. Journal Of Buon. 2019 Jan-Feb;24(1):106-115. PubMed PMID: 30941958 – 1.695
ARTICOLE PUBLICATE 2017
Gulei D, Berindan-Neagoe I. CRISPR/Cas9: A Potential Life-Saving Tool. What’s next? Molecular Therapy – Nucleic Acids. 2017 Dec 15;9:333-336.doi: 10.1016/j.omtn.2017.10.013, 5.66
Irimie AI, Braicu C, Sonea L, Zimta AA, Cojocneanu-Petric R, Tonchev K, Mehterov N, Diudea D, Buduru S, Berindan-Neagoe I. A Looking-Glass of Non- coding RNAs in oral cancer. International Journal of Molecular Sciences. 2017 Dec 5;18(12). pii: E2620. doi:10.3390/ijms18122620, 3.687
Obasi TC, Moldovan R, Toiu A, Braicu C, Bodoki E, Berindan-Neagoe I, Oniga I, Sandulescu R, Oprean R. Molecular-trapping in Emulsion’s Monolayer: A New Strategy for Production and Purification of Bioactive Saponins. Scientific Reports. 2017 Nov 6;7(1):14511. doi: 10.1038/s41598-017-15067-4, 4.122
Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I. The new era of nanotechnology, an alternative to change cancer treatment. Drug Design Development and Therapy. 2017 Sep 27;11:2871-2890. doi: 10.2147/DDDT.S142337, 2.935
Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I. miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. OncoTargets and Therapy.2017 Aug 28;10:4225-4238. doi: 10.2147/OTT.S137107, 2.656
Irimie AI, Sonea L, Jurj A, Mehterov N, Zimta AA, Budisan L, Braicu C, Berindan-Neagoe I. Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer.International Journal of Nanomedicine. 2017 Jun 26;12:4593-4606. doi:10.2147/IJN.S133219, 4.37
Pop-Bica C, Gulei D, Cojocneanu-Petric R, Braicu C, Petrut B, Berindan-Neagoe I. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. International Journal of Molecular Sciences. 2017 Jul 13;18(7). pii:E1514. doi: 10.3390/ijms18071514, 3.687
Braicu C, Mehterov N, Vladimirov B, Sarafian V, Nabavi SM, Atanasov AG, Berindan-Neagoe I. Nutrigenomics in cancer: Revisiting the effects of natural compounds. Seminars in Cancer Biology. 2017 Oct;46:84-106. doi:10.1016/j.semcancer.2017.06.011, 10.198
Chira S, Gulei D, Hajitou A, Zimta AA, Cordelier P, Berindan-Neagoe I. CRISPR/Cas9: Transcending the Reality of Genome Editing. Molecular Therapy – Nucleic Acids. 2017 Jun 16;7:211-222. doi: 10.1016/j.omtn.2017.04.001, 5.66
Budisan L, Gulei D, Zanoaga OM, Irimie AI, Sergiu C, Braicu C, Gherman CD, Berindan-Neagoe I. Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer. International Journal of Molecular Sciences. 2017 Jun1;18(6). pii: E1178. doi: 10.3390/ijms18061178, 3.687
Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez- Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA. N-BLR, a primate- specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biology. 2017 May 24;18(1):98. doi: 10.1186/s13059-017-1224-0, 13.214
Gulei D, Mehterov N, Ling H, Stanta G, Braicu C, Berindan-Neagoe I. The „good- cop bad-cop” TGF-beta role in breast cancer modulated by non-coding RNAs. Biochimica Et Biophysica Acta-General Subjects. 2017 Jul;1861(7):1661-1675. doi:10.1016/j.bbagen.2017.04.007, 3.679
Cătană CS, Pichler M, Giannelli G, Mader RM, Berindan-Neagoe I. Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma. Oncotarget. 2017 Apr 25;8(17):29519-29534. doi: 10.18632/oncotarget.15706, 0
Dima D, Tomuleasa C, Frinc I, Pasca S, Magdo L, Berindan-Neagoe I, Muresan M, Lisencu C, Irimie A, Zdrenghea M. The use of rotation to fentanyl in cancer-related pain. Journal of Pain Research. 2017 Feb 9;10:341-348. doi: 10.2147/JPR.S121920. eCollection 2017,2.645
Boca S, Berce C, Jurj A, Petrushev B, Pop L, Gafencu GA, Selicean S, Moisoiu V, Temian D, Micu WT, Astilean S, Braicu C, Tomuleasa C, Berindan-Neagoe I. Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia. Medical Hypotheses. 2017 Nov;109:42-45. doi:10.1016/j.mehy.2017.09.023. Epub 2017 Sep 27, 1.12
Goblirsch M, Richtig G, Slaby O, Berindan-Neagoe I, Gerger A, Pichler M. MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy. Pharmacogenomics. 2017 Jul;18(10):1027-1038, 2.302
Jurj A, Tomuleasa C, Tat TT, Berindan-Neagoe I, Vesa SV, Ionescu DC. Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study. The Journal of Gastrointestinal and Liver Diseases. 2017 Mar;26(1):45-50, 1.964
Nagy-Simon T, Tatar AS, Craciun AM, Vulpoi A, Jurj MA, Florea A, Tomuleasa C, Berindan-Neagoe I, Astilean S, Boca S. Antibody Conjugated, Raman Tagged Hollow Gold-Silver Nanospheres for Specific Targeting and Multimodal Dark- Field/SERS/Two Photon-FLIM Imaging of CD19(+) B Lymphoblasts . ACS Applied Materials & Interfaces. 2017 Jun 28;9(25):21155-21168, 8.097
Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes- Mattei E, Xiao L, Vannini I, Redis RS, D’Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan- Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clinical Cancer Research. 2017 Jun 1;23(11):2891-2904.doi: 10.1158/1078-0432.CCR-16-1025, 10.199
El Ouar I, Braicu C, Naimi D, Irimie A, Berindan-Neagoe I. Effect of Helix aspersa extract on TNF alpha, NF-kappa B and some tumor suppressor genes in breast cancer cell line Hs578T. Pharmacognosy Magazine. 2017 Apr-Jun;13(50):281-285, 1.525
Tomuleasa C, Zaharie F, Muresan MS, Pop L, Fekete Z, Dima D, Frinc I, Trifa A, Berce C, Jurj A, Berindan-Neagoe I, Zdrenghea M. How to Diagnose and Treat a Cancer of Unknown Primary Site. The Journal of Gastrointestinal and Liver Diseases. 2017 Mar;26(1):69-79. doi: 10.15403/jgld.2014.1121.261.haz, 1.964
Frinc I, Dima D, Chitic M, Berce C, Berindan-Neagoe I, Tat T, Tanase A, Tomuleasa C, Bojan A. Transthoracic ultrasonography for the follow-up of a chronic lymphocytic leukemia patient with chemotherapy-induced immunosuppression prior to allogeneic stem cell transplantation. A case report. Medical Ultrasonography. 2017 Mar 14;19(3):330-332. doi: 10.11152/mu-976, 1.512
Marin DE, Braicu C, Gras MA, Pistol GC, Petric RC, Berindan Neagoe I, Palade M,Taranu I. Low level of ochratoxin A affects genome- wide expression in kidney of pig. Toxicon. 2017 Sep 15;136:67-77. 2.352
Messinger CJ, Gurzau ES, Breitschwerdt EB, Tomuleasa CI, Trufan SJ, Flonta MM, Maggi RG, Berindan-Neagoe I, Rabinowitz PM. Seroprevalence of Bartonella species, Coxiella burnetii and Toxoplasma gondii among patients with hematological malignancies: A pilot study in Romania. Zoonoses and Public Health. 2017 Sep;64(6):485-490. doi: 10.1111/zph.12353, 2.688
Tirinescu DC, Tomuleasa C, Pop L, Bondor CI, Vlăduţiu DŞ, Paţiu IM, Rusu CC, Moldovan DT, Potra A, Kacsó IM. Matrix-Metalloproteinase-2 Predicts Arteriovenous Fistula Failure in Hemodialysis Patients. Therapeutic Apheresis And Dialysis. 2017 Dec;21(6):586-591. doi: 10.1111/1744-9987.12584, 1.416
Brem B, Gal E, Găină L, Silaghi-Dumitrescu L, Fischer-Fodor E, Tomuleasa CI, Grozav A, Zaharia V, Filip L, Cristea C. Novel Thiazolo[5,4-b] phenothiazine Derivatives: Synthesis, Structural Characterization, and In Vitro Evaluation of Antiproliferative Activity against Human Leukaemia International Journal Of Molecular Sciences. 2017 Jun 26;18(7). pii: E1365. doi: 10.3390/ijms18071365, 3.687
Gafencu GA, Tomuleasa CI, Ghiaur G. PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative . Medical Hypotheses. 2017 Jul;104:30-34. doi: 10.1016/j.mehy.2017.05.015, 1.12
Berce C, Tomuleasa C, Meza R. Horizon 2020: Funds to help Eastern Europe close the gap. Nature. 2017 Jan 11;541(7636):157, 41.577
Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C. Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR-ABL transcripts. Oncotargets And Therapy. 2017 Oct 19;10:5047-5051, 2.656
Fischer-Fodor E, Mikláš R, Rišiaňová L, Cenariu M, Grosu IG, Virag P, Perde-Schrepler M, Tomuleasa C, Berindan-Neagoe I, Devínsky F, Miklášová N. Novel Palladium(II) Complexes that Influence Prominin-1/ CD133 Expression and Stem Cell Factor Release in Tumor Cells. Molecules. 2017 Mar 30;22(4). pii: E561, 3.098
ARTICOLE PUBLICATE 2016
Baritchii Adriana; Jurj Anca; Soritau Olga; Tomuleasa Ciprian; Raduly Layos; Zanoaga Oana; Cernea Dana; Braicu Cornelia; Neagoe Ioana; Florian Ioan Stefan. Sensitizer drugs for the treatment of temozolomide-resistant glioblastoma. Journal of Buon, JAN-FEB 2016. Volume: 21 Issue: 1 Pages: 199-207, 1.344
Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I. Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy. International Journal of Nanomedicine. 2016 Feb 15;11:641-60. doi: 10.2147/IJN.S94064, 4.3
Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio AL, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non- coding RNA CCAT2. Molecular Cell. 2016 Feb-18;6(4):520-34. doi:110.1016/j. molcel. 2016.01.015, 14.714
Gherman C, Braicu OL, Zanoaga O, Jurj A, Pileczki V, Maralani M, Drigla F, Braicu C, Budisan L, Achimas-Cadariu P, Berindan-Neagoe I. Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition- related genes in ovarian cancer cells A2780 and A2780cis. Molecular and Cellular Biochemistry. 2016 Feb;413(1-2):189-98. doi: 10.1007/s11010-015-2652-3, 2.669
Tanase A, Tomuleasa C, Marculescu A, Bardas A, Colita A, Orban C, Ciurea SO. Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease? Acta Haematologica. 2016;135(4):211-6. doi: 10.1159/000443469. Epub 2016 Feb 26, 1.205
Gafencu GA, Selicean SE, Petrushev B, Cucuianu A, Dima D, Frinc I, Irimie A, Pileczki V, Berindan-Neagoe I, Berce C, Buiga R, Tomuleasa C. Clinicopathological analysis of a case series of peripheral T-cell lymphomas, not otherwise specified, of lymphoepithelioid variant (Lennert’s lymphoma). A Central European single-center study. Human Pathology – 2016 – Mar 22. pii: S0046-8177(16)00079-4. doi: 10.1016/j.humpath.2015.12.033, 3.014
Brammer JE, Khouri I, Gaballa S, Anderlini P, Tomuleasa C, Ahmed S, Ledesma C, Hosing C, Champlin RE, Ciurea SO. Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning. Biology of Blood and Marrow Transplantation. 2016 Mar;22(3):493-8. doi: 10.1016/j.bbmt.2015.10.015, 4.704
Loredana Ungureanu , Lavinia Grigore , Loredana Balacescu , Ioana Berindan- Neagoe ,Rodica M Cosgarea , Ovidiu Balacescu. Expression of Tissue Markers in Malignant and Benign Melanocytic Proliferations – a Comparative Study. Romanian Biotechnological Letters, Mar-Apr 2016. Volume: 21 Issue: 2 Pages: 11365-11371, 0.396
Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma .International Journal of Molecular Sciences 2016 (apr) -17(4). pii: E573. doi: 10.3390/ijms17040573, 3.226
Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I. Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors. OncoTargets and Therapy. 2016, Jun 2;9:3369-80. doi: 10.2147/OTT.S97519,2.612
Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock MD, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose JN, Packham GK, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami AH, Călin GA, Nicoloso MS. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut, 2016, Jun;65(6):977-89. doi: 10.1136/gutjnl-2015-309372, 16.658
Suarasan S, Simon T, Boca S, Tomuleasa C, Astilean S. Gelatin-coated Gold Nanoparticles as Carriers of FLT3 Inhibitors for Acute Myeloid Leukemia Treatment. Chemical Biology & Drug Design. 2016 Jun;87(6):927-35. doi: 10.1111/cbdd.12725, 2.396
Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, Rondon G, Chen J, Hammerstrom A, Lombardi L, Alatrash G, Korbling M, Oran B, Kebriaei P, Ahmed S, Shah N, Rezvani K, Marin D, Bashir Q, Alousi A, Nieto Y, Qazilbash M, Hosing C, Popat U, Shpall EJ, Khouri I, Champlin RE, Ciurea SO. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 2016 Jul 12. doi: 10.1002/cncr.30180, 6.072
Tatar AS, Nagy-Simon T, Tomuleasa C, Boca S, Astilean S.J. Nanomedicine approaches in acute lymphoblastic leukemia. Journal Of Controlled Release. 2016 Jul 23. pii: S0168-3659(16)30470-9, 7.786
Braicu C, Cojocneanu-Petric R, Jurj A, Gulei D, Taranu I, Gras AM, Marin DE, Berindan-Neagoe I. Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health. BMC Genomics. 2016 Aug 17;17:646. doi: 10.1186/s12864-016-2984-8, 3.729
Irimie AI, Braicu C, Pileczki V, Petrushev B, Soritau O, Campian RS, Berindan- Neagoe I. Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells. Molecular and Cellular Biochemistry. 2016 Aug;419(1-2):75-82. doi: 10.1007/s11010-016-2751-9, 2.669
Cornelia Braicu,Sonia Selicean,Roxana Cojocneanu-Petric,Raduly Lajos,Ovidiu Balacescu,Ionelia Taranu,Daniela Eliza Marin,Monica Motiu, Ancuta Jurj,Patriciu Achimas-Cadariu and Ioana Berindan-Neagoe. Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology. BMC Genomics. 2016 Aug 9;17:576. doi: 10.1186/s12864-016-2830-z. 3.729
Dima D, Tomuleasa C, Zdrenghea M. Henoch Schonlein purpura and Clostridium difficile infection: a hematologist’s point of view. Journal Of Gastrointestinal And Liver Diseases. 2016 Sep;25(3):411. doi: 10.15403/jgld.2014.1121.253.sch., 1.837
Berce C, Lucan C, Petrushev B, Boca S, Miclean M, Sarpataki O, Astilean S, Buzoianu A, Tomuleasa C, Bojan A. In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice. International journal of nanomedicine. 2016 Sep 1;11:4261-73. doi: 10.2147/IJN.S108711. eCollection 2016, 4.300
Sanda Boca, Ciprian Lucan, Ioana Frinc, Bobe Petrushev, Timea Simon, Cristian Berce, Grigore-Aristide Gafencu, Delia Dima, Alina Tanase, Sonia Selicean, Valentina Pileczki, Laura Pop, Vlad Moisoiu, Anca Buzoianu, Adrian Florea, Alexandru Irimie, Simion Astilean, Anca Bojan, Ioana Berindan-Neagoe, Ciprian Tomuleasa. Gold nanoparticles conjugated with rituximab for the treatment of chronic lymphocytic leukaemia, Farmacia, SEP-OCT 2016, Volume: 64 Issue: 5 Pages: 688-698, 1.348
Balacescu O, Balacescu L, Virtic O, Visan S, Gherman C, Drigla F, Pop L, Bolba-Morar G, Lisencu C, Fetica B, Tudoran O, Berindan-Neagoe I. Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients. Mediators of Inflammation, 2016:3239167. doi: 10.1155/2016/3239167, 3.232
Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, Del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I. Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells. OncoTargets and Therapy. 2016 Nov 11;9:6921-6933, 2.612
Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E, Paradiso A, Achimas-Cadariu P, Lazar V, Berindan-Neagoe I. Novel insight into triple- negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy. Expert Reviews in Molecular Medicine. 2016 Nov 7;18:e18, 4.405
ARTICOLE PUBLICATE 2015
Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Călin GA. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death and Differentiation. 2015 Ian, 22(1):34-45. doi: 10.1038/cdd.2014.130, 8.218
Ţăranu I, Braicu C, Marin DE, Pistol GC, Moţiu M, Bălăcescu L, Berindan Neagoe I, Burlacu R., Exposure to zearalenone mycotoxin alters in vitro porcine intestinal epithelial cells by differential gene expression. Toxicology Letters. 2015,Ian 5; 232(1): 310-325. doi: 10.1016/j.toxlet.2014.10.022, 3.522
Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I. Clinical and pathological implications of miRNA in bladder cancer. International Journal of Nanomedicine. 2015 Jan 20;10:791-800. doi: 10.2147/IJN.S72904. eCollection 2015, 4.320
Orsolya M, Attila-Zoltan M, Gherman V, Zaharie F, Bolboaca S, Chira C, Bodolea C, Tomuleasa C, Irimie A, Coman I, Ionescu D. The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology . Journal Of Buon. 2015 Jan-Feb;20(1):317-24, 0.880
Irimie AI, Braicu C, Zănoagă O, Pileczki V, Gherman C, Berindan-Neagoe I, Câmpian RS. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells. OncoTargets and Therapy. 2015, Feb 20; 8:461-70. doi: 10.2147/OTT.S78358 2.272
Tomuleasa C, Dima D, Frînc I, Paţiu M, Petrushev B, Cucuianu A, Berindan- Neagoe I. BCR-ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second- line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice. Leukemia & Lymphoma. 2015, Feb; 56(2): 546-7. doi: 10.3109/10428194.2014.940582, 3.093
Tudoran OM, Soriţău O, Bălăcescu L, Pop L, Meurice G Vişan S, Lindberg S, Eniu A, Langel U, Bălăcescu O, Berindan-Neagoe I. PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signaling pathways to sustain tumorigenic stimulation. Journal of Cellular and Molecular Medicine. 2015 (feb), Volume 19, Issue 2, pages 371–382. doi: 10.1111/jcmm.12449, 4.938
Peng H, Ishida M, Li L, Saito A, Kamiya A, Hamilton JP, Fu R, Olaru AV, An F, Popescu I, Iacob R, Dima S, Alexandrescu ST, Grigorie R, Nastase A, Berindan-Neagoe I, Tomuleasa C, Graur F, Zaharia F, Torbenson MS, Mezey E, Lu M, Şelaru FM. Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma.Oncotarget. 2015, Mar 20;6(8):5666-77, 5.008
Susman Sergiu ; Barnoud Raphaelle ; Bibeau Frederique ; Borini Francesco ; Pocard Marc ; Tomuleasa Ciprian ; Sabourin Jean-Cristophe- The Lauren Classification Highlights the Role of Epithelial-to-Mesenchymal Transition in Gastric Carcinogenesis: an Immunohistochemistry Study of the STAT3 and Adhesion Molecules Expression . Journal Of Gastrointestinal And Liver Diseases. 2015 Mar;24(1):77-83. doi: 10.15403/jgld.2014.1121.sus, 1.891
Mureşan M, Zaharie F, Bojan A, Frînc I, Dima D, Selicean S, Gafencu GA, Petrushev B, Cojocneanu-Petric R, Tefas C, Cioca A, Irimie A, Berce C, Berindan-Neagoe I, Tomuleasa C, Achimaş-Cadariu P. MicroRNAs in liver malignancies. Basic science applied in surgery. Journal of BUON. 2015,Mar-Apr;20 (2):361-75, 0.880
Gherman Claudia; Tudor Matea Cristian; Constantin Bele; Flaviu Tăbăran; Ştefan Razvan; Maria Bindea; Chira Sergiu ; Braicu Cornelia, Pop Laura; Petric Roxana Cojocneanu; Berindan-Neagoe Ioana. Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis . Journal of Nanoscience and Nanotechnology. 2015 (apr), Volume: 15, Issue: 4,Pages:2865- 2869. doi: 10.1166/jnn.2015.9845, 1.338
Braicu C, Pileczki V, Pop L, Petric RC, Chira S, Pointiere E, Achimaş-Cadariu P, Berindan-Neagoe I. Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model. PLoS One 2015, Apr 7;10(4). doi: 10.1371/journal.pone.0120936, 3.057
Irimie AI, Braicu C, Cojocneanu-Petric R, Berindan-Neagoe I, Câmpian RS. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics. Acta Odontologica Scandinavica, 2015, Apr;73(3):161-8. doi: 10.3109/00016357.2014.986754, 1.171
Cucuianu Andrei ; Petrushev Bobe ; Crisan Doinita ; Buiga Rares ; Rosu Ana-Maria ; Dima Delia ; Tomuleasa Ciprian. Chronic granulomatous dermatosis as a presenting sign of cutaneous T-cell lymphomas. European Journal of Dermatology , Apr 2015, Volume: 25,Issue: 2,Pages: 210-210 2.069. DOI: 10.1684/ejd.2015.2530, 1.577
Cătană CS, Berindan Neagoe I, Cozma V, Magdaş C, Tăbăran F, DumitraşcuDL. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology. 2015, (May 21) ;21 (19):5823-30. DOI: 10.3748/wjg.v21.i19.5823, 2.787
Gina Cecilia Pistol, Cornelia Braicu, Monica Motiu, Mihail Alexandru Gras, Daniela Eliza Marin, Mariana Stancu, Loredana Călin, Florentina Israel- Roming, Ioana Berindan-Neagoe, Ionelia Taranu. Zearalenone Mycotoxin Affects Immune Mediators, MAPK Signalling Molecules, Nuclear Receptors and Genome-Wide Gene Expression in Pig Spleen. PLoS One. 2015 May 26;10(5):e0127503. doi: 10.1371/journal.pone.0127503. eCollection 2015, 3.057
Bochiş OV, Irimie A, Pichler M, Berindan-Neagoe I. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer. The Journal of Gastrointestinal and Liver Diseases, 2015,Jun;24 (2):225-34, 1.891
Vladimir Lazar, Eitan Rubin, Stephane Depil, Yudi Pawitan, Jean-François Martini, Jesus Gomez-Navarro, Antoine Yver, Zhengyin Kan, Jonathan R. Dry, Jeanne Kehren, Pierre Validire, Jordi Rodon, Philippe Vielh, Michel Ducreux, Susan Galbraith, Manfred Lehnert, Amir Onn, Raanan Berger, Marco A. Pierotti, Angel Porgador, CS Pramesh, Ding-wei Ye, Andre L. Carvalho, Gerald Batist, Thierry Le Chevalier, Philippe Morice, Benjamin Besse, Gilles Vassal, Andrew Mortlock, Johan Hansson, Ioana Berindan-Neagoe, Robert Dann, Joel Haspel, Alexandru Irimie, Steve Laderman, Hovav Nechushtan, Amal S. Al Omari, Trent Haywood, Catherine Bresson, Khee Chee Soo, Iman Osman, Hilario Mata, Jack J. Lee, Komal Jhaveri, Guillaume Meurice, Gary Palmer, Ludovic Lacroix, Serge Koscielny, Karina Agda Eterovic, Jean-Yves Blay, Richard Buller, Alexander Eggermont, Richard L. Schilsky, John Mendelsohn, Jean-Charles Soria, Mace Rothenberg, Jean-Yves Scoazec, Waun Ki Hong, Razelle Kurzrock. A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer. Oncotarget. 2015, June 10; 6(16): 14139–14152. DOI: 10.18632/oncotarget.3741, 5.008
Fischer-Fodor Eva, Miklas, Roman, Krausz Ludovic Tibor, ; Virag, Piroska, Moldovan Daniela Cristina, Schrepler, Maria Perde, Berindan-Neagoe Ioana, Devinsky, Ferdinand, Miklasova Natalia. Immunomodulatory potential of palladium(II) complexes with (1E,6E)-1,7-bis (3,4-dimethoxyphenyl) hepta- 1,6-diene-3,5-dione. Studia Universitatis Babes-Bolyai Chemia. Jun 2015, Volume: 60, Issue: 2, Pages: 93-100, 0.148
Zaharie F, Cojocneanu-Petric R, Mureşan M, Frînc I, Dima D, Petrushev B, Tanase A, Berce C, Chitic M, Berindan-Neagoe I, Pileczki V, Irimie A, Tomuleasa C. Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation. International Journal of Nanomedicine. 2015, Jul 31;10:4897-9. doi: 10.2147/IJN.S87405, 4.320
Tomuleasa C, Fuji S, Cucuianu A, Kapp M, Pileczki V, Petrushev B, Selicean S, Tanase A, Dima D, Berindan-Neagoe I, Irimie A, Einsele H. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation. Annals Of Hematology. 2015, Jul;94(7):1081-92, 3.022
Cojocneanu Petric R, Braicu C, Raduly L, Zănoagă O, Dragoş N, Monroig P, Dumitraşcu D,Berindan-Neagoe I. Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers. OncoTargets and Therapy, 2015, Aug 6;8:2053-66, doi: 10.2147/OTT.S83597, 2.272
Petric RC, Braicu C, Bassi C, Pop L, Ţăranu I, Dragos N, Dumitraşcu D, Negrini M, Berindan-Neagoe I. Interspecies Gene Name Extrapolation-A New Approach. PLoS One, 2015, Sep 25;10(9), doi: 10.1371/journal.pone.0138751, 3.057
Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Călin GA. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene, 2015, Sept, 34, 5003-5011, doi: 10.1038/onc.2014.456, 7.932
Mânzat-Săplăcan RM, Mircea PA, BălăcescuL, Chira RI, Berindan-Neagoe I, Bălăcescu O. Can we change our microbiome to prevent colorectal cancer development? Acta Oncologica, 2015, Sep;54 (8):1085-95, doi: 10.3109/0284186X.2015.1054949, 3.730
Tomuleasa C, Akin-Abayomi E, Dima D, Tefas C, Irimie A, Petrushev B, Frinc I, Grewal. Do lymphomas have an autoimmune background and how can we increase the sensitivity of the diagnosis of primary pancreatic lymphoma with relatively small samples ? Journal Of Gastrointestinal And Liver Diseases. 2015, Sep;24(3):391-2, 1.891
Scrobota Ioana; Alb Camelia; Calniceanu Horia; Baciut Grigore; Neagoe Ioana Berindan; Onisei Doina; Popovici Amina Ramona; Buzatu Roxana; Bolfa Pompei. Assessment of Serum Lipid Peroxidation and Redox Thiol System Status in Different Stages of Oral Careinogenesis. Revista De Chimie. Sep 2015,Volume: 66 Issue: 9 Pages: 1467-1470, 0.956
Roberta M. Mânzat-Săplăcan, Loredana Bălăcescu, Claudia Gherman, Simona Vişan, Romeo I. Chira, Adriana Binţinţan, Georgiana Nagy, Cornelia Popovici, Simona D. Vălean, Craiu Anca, Vasile Binţinţan, Răzvan Scurtu, Petru A. Mircea, Ioana Berindan-Neagoe, Tudor E. Ciuleanu, Ovidiu Bălăcescu. Is there a correlation between peripheral blood expression of angiogenic transcriptional factors/receptors and colorectal cancer? Journal of BUON. 2015, (Sep-Oct); 20(5): 1193-1200, 0.880
Chira S, Jackson CS, Oprea I, Ozturk F, Pepper MS, Diaconu I, Braicu C, Raduly LZ, Călin GA, Berindan-Neagoe I. Progresses towards safe and efficient gene therapy vectors. Oncotarget. 2015, Oct 13;6(31):30675-703, 5.008
Grewal R, Cucuianu A, Swanepoel C, Dima D, Petrushev B, Pop B, Berindan- Neagoe I, Abayomi EA, Tomuleasa C. The role of microRNAs in the pathogenesis of HIV-related lymphomas. Critical Reviews in Clinical Laboratory Sciences. 2015, Oct;52(5):232-41, doi: 10.18632/oncotarget.5169, 4.167
Tudoran O, Vîrtic O, Bălăcescu L, Lisencu C, Fetica B, Gherman C, Bălăcescu O, Berindan-Neagoe I. Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response. OncoTargets and Therapy. 2015 Nov 18;8:3415-23. doi: 10.2147/OTT.S91720, 2.272
Grozav A, Bălăcescu O, Bălăcescu L, Cheminel T, Berindan-Neagoe I, Therrien B. Synthesis, Anticancer Activity and Genome Profiling of Thiazolo Arene Ruthenium Complexes. Journal Of Medicinal Chemistry. 2015, Nov 12;58(21):8475-90. 10.1021/acs.jmedchem.5b00855, 5.589
Tudoran O, O, Bălăcescu L, Vişan S, Barbos O, Cojocneanu-Petric R, BălăcescuO, Berindan-Neagoe I. Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells. Molecular and Cellular Biochemistry. 2015, (Nov) 409 (1-2):163-76. DOI: 10.1007/s11010-015-2522-z, 2.613
Zaharie F, Ciorogar G, Zaharie R, Mocan T, Zdrehus C, Mocan L, Berindan- Neagoe I, Achimas P, Iancu C, Tomus C. Laparoscopic rectal resection versus conventional open approach for rectal cancer – a 4-year experience of a single center – Journal of BUON. 2015 Nov-Dec;20(6):1447-55, 0.880
Zaharie F, Muresan MS, Petrushev B, Berce C, Gafencu GA, Selicean S, Jurj A, Cojocneanu-Petric R, Lisencu CI, Pop LA, Pileczki V, Eniu D, Muresan MA, Zaharie R, Berindan-Neagoe I, Tomuleasa C, Irimie A. Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer. Journal of Gastrointestinal and Liver Diseases. 2015 Dec;24(4):435-43.doi: 10.15403/jgld.2014.1121.244.375, 1.891
Simon T, Tomuleasa C, Bojan A, Berindan-Neagoe I, Boca S, Aştilean S. Design of FLT3 Inhibitor – Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia. Nanoscale Research Letters. 2015 Dec;10 (1):466., 2.584
Iulia Irimie A, Braicu C, Zanoaga O, Pileczki V, Soritau O, Berindan-Neagoe I, Septimiu Campian R. Inhibition of tumor necrosis factor alpha using RNA interference in oral squamous cell carcinoma. Journal of BUON, 2015 Jul-Aug;20(4):1107-14, 0.880
ARTICOLE PUBLICATE 2014
Ligia Balanean, Cornelia Braicu, Ioana Berindan-Neagoe, Cristina Nastasa, Brindusa Tiperciuc, Philippe Verite, Ovidiu Oniga Synthesis of novel 2- metylamino-4-substituted-1,3-thiazoles Chemistry Magazine, volume 2014, December 1413 -1417, 0.81
Dima D, Tomuleasa C, Irimie A, Florian IS, Petrushev B, Berindan-NeagoeI,Cucuianu A.Magnetic resonance imaging- based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin,vincristine, prednisone, and rituximab. Cancer.2014Dec 15;120(24):4005-6, 5.068
Grozav Adriana; Gaină Luiza Ioana; Pileczki Valentina; Crişan Ovidiu; Silaghi Dumitrescu Luminiţa; Therrien Bruno; Zaharia Valentin; Berindan- Neagoe Ioana , The Synthesis and Antiproliferative Activities of New Arylidene-Hydrazinyl-Thiazole Derivatives. International Journal of Molecular Sciences., 2014, ( dec) Volume: 15,Issue: 12, 22059-22072, 2.862
Berindan-Neagoe Ioana; Călin, George A –Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment, Clinical Cancer Research, 2014, (dec) 20, 24,Pages: 6247-6253, 8.722
Braicu C, Cătană C, Călin GA, Berindan-Neagoe I., NCRNA- Combined Therapy as Future Treatment Option for Cancer – Current Pharmaceutical Design., 2014, (nov) 20(42):6565-74, 3.452
Ionescu Călin; Braicu Cornelia; Chiorean Roxana; Petric Roxana Cojocneanu; Neagoe Emilian; Pop Laura; Chira Sergiu; Berindan-Neagoe Ioana – TIMP-1 Expression in Human Colorectal Cancer Is Associated with SMAD3 Gene Expression Levels: A Pilot Study – The Journal of Gastrointestinal and Liver Diseases, 2014, (dec), Volume: 23,Issue: 4,Pages: 413-418, 2.202
Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Călin GA. – MicroRNAome genome: a treasure for cancer diagnosis and therapy – CA: A Cancer Journal for Clinicians, 2014, Sep- Oct;64(5):311-36, 144.8
Tudoran Oana; Vîrtic Oana; Bălăcescu Loredana; Pop Laura; Drâglă Flaviu; Eniu Alexandru; Fetica Bogdan; Bălăcescu Ovidiu; Berindan-Neagoe Ioana Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients, – PLoS One, 2014,(jul) Volume: 9 Issue: 7, 3.234
Tomuleasa Ciprian; Braicu Cornelia; Irimie Alexandra; Craciun Lucian; Berindan-Neagoe Ioana, Nanopharmacology in translational hematology and oncology – International Journal of Nanomedicine, 2014, (jul)Volume: 9 Pages: 3465-3479, 4.383
Kojima Seiji; Cucuianu Andrei; Takahashi Yoshiyuki; Berindan-Neagoe Ioana; Florian Ioan-Ştefan; Dima Delia; Tomuleasa Ciprian – Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies – International Journal of Nanomedicine, 2014, (jul)Volume: 9 Pages: 3247-3248, 4.383
Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GA. –Epigenetically regulated microRNAs and their prospect in cancer diagnosis, Expert Review of Molecular Diagnostics. 2014, (jul) Volume: 14 Issue: 6 Pages: 673-683, 3.516
Tomuleasa Ciprian; Giannelli Gianluigi; Cucuianu Andrei; Aldea Mihaela; Paradiso Angelo; Berindan-Neagoe Ioana, Interplay Between Cancer Cells, Macrophages and Natural Killer Cells May Actually Decide the Outcome of Therapy With Sorafenib –Hepatology, 2014, (jul) Volume: 60 Issue: 1Pages: 430-430, 11.055
Berindan-Neagoe I.; Paradiso A. – Is there a role of Eastern Europe in cancer biomarkers for personalized cancer medicine? Cancer Biomarkers, 2014, (jun) Volume: 14 Issue: 2-3 Pages: 85-86, 1.721
Pop Laura-Ancuţa; Puşcaş Emil; Pileczki Valentina; Cojocneanu-Petric Roxana; Braicu Cornelia; Achimaş-Cadariu Patriciu; Berindan-Neagoe Ioana- Quality control of Ion Torrent sequencing library, Cancer Biomarkers, 2014, (jun) Volume: 14 Issue: 2-3, Pages: 93-101, 1.721
Braicu Cornelia; Berindan-Neagoe Ioana; Pileczki Valentina; Cojocneanu- Petric Roxana; Pop Laura-Ancuţa; Puşcaş Emil; Irimie Alexandru; Buiga Rareş – Breast tumor bank: An important resource for developing translational cancer research in România – Cancer Biomarkers, 2014, (jun) Volume: 14 Issue: 2-3 Pages: 119-127, 1.721
Fetica Bogdan; Bălăcescu Ovidiu; Bălăcescu Loredana; Rus Meda; Berindan-Neagoe Ioana, – An alternative and sensitive method based on LCM and Q-PCR for HER2 testing in breast cancer – Cancer Biomarkers, 2014,(jun) Volume: 14 Issue: 2-3 Pages: 129-135, 1.721
Şuşman Sergiu; Tomuleasa Ciprian; Fekete Zsolt; Pilato Brunella; Irimie Alexandru; Berindan-Neagoe Ioana, The importance of microRNAs in the stroma-breast cancer cell interplay – Cancer Biomarkers, 2014, (jun) Volume:14 Issue: 2-3 Pages: 137-144, 1.721
Chiorean Roxana; Berindan-Neagoe Ioana; Braicu Cornelia; Florian Ştefan; Leucuţa Daniel; Crişan Doiniţa; Cernea Valentin – Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: Correlations with clinical data – Cancer Biomarkers, 2014, (jun) Volume: 14 Issue: 2-3 Pages: 185-194, 1.721
Mihaela Aldea, Lucian Crăciun, Ciprian Tomuleasa, Ioana Berindan-Neagoe, Gabriel Kacso, Ioan Ştefan Florian, Carmen Crivii – Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery, Tumor Biologyl. 2014, (jun) Volume: 35 Issue: 6 Pages: 5101-5110, 3.611
Aldea Mihaela D.; Petrushev Bobe; Soriţău Olga; Tomuleasa Ciprian I.; Berindan-Neagoe Ioana; Filip Adriana G.; Cherecheş Gabriela; Cenariu Mihai; Crăciun Lucian; Tatomir Corina; Florian Ioan-Ştefan; Crivii Carmen B.; Kacso Gabriel Metformin plus sorafenib highly impacts temozolomide- resistant glioblastoma stem-like cells – Journal of BUON, 2014, (apr-jun) Volume: 19 Issue: 2 Pages: 502-511,0.741
Ioana Frînc, Mihai-Ştefan Mureşan, Florin Zaharie, Ljubomir Petrov, Cristian Berce, Alexandra Irimie, Ioana Berindan-Neagoe,Ciprian Tomuleasa – Cancer stem –like cells: the dark knights of clinical hematology and oncology, Journal of BUON, 2014, (april-jun) 19(2): 328-335, 0.741
Bălăcescu Ovidiu; Bălăcescu Loredana; Tudoran Oana; Todor Nicolae; Rus Meda; Buiga Rares; Şuşman Sergiu; Fetica Bogdan; Pop Laura; Maja Laura; Vişan Simona; Ordeanu Claudia; Berindan-Neagoe Ioana; Nagy Viorica – Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure – BMC Cancer, 2014, (april) Volume: 14, Article Number: 246, 3.362
Chedea VS, Braicu C, Chirilă F, Ogola HJ, Pelmuş RŞ, Călin LG, Socaciu C Antioxidant/Prooxidant and antibacterial/probacterial effects of a grape seed extract in complex with lipoxygenase, – Biomed Research International, Article 2014, ID 313684, 1.441
Miron N, Feldrihan V, Neagoe IB, Cristea V- The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice – Immunological Investigations. , 2014, (dec) Vol. 43, No. 3 , Pages 267-277, 1.991
Tomuleasa Ciprian; Florian Ioan Ştefan; Berce Cristian; Irimie Alexandru; Berindan-Neagoe Ioana; Cucuianu Andrei Tomuleasa Ciprian; Florian Ioan Ştefan; Berce Cristian; Irimie Alexandru; Berindan-Neagoe Ioana; Cucuianu Andrei – MRI-based identification of undifferentiated cells: looking at the two faces of Janus, International Journal of Nanomedicine, 2014, (febr) Volume: 9 Pages: 865-866, 4.383
Li Ling; Zhou Liya; Li, Yuwen; Lin SR Sanren; Tomuleasa Ciprian – MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog – Journal Of Buon,2014 Volume: 19,Issue: 1,Pages: 228-236, 0.741
Gherman Vitalie ; Tomuleasa Ciprian ; Bungardean Catalina ; Crisan Nicolae ; Ona Victor-Dan ; Feciche Bogdan;Irimie Alexandru; Coman Ioan- Management of renal extraskeletal mesenchymal chondrosarcoma. BMC Surgery 2014,Volume: 14,Article Number: 107, 1.469
Li L, Masica D, Ishida M, Tomuleasa C, Umegaki S, Kalloo AN, Georgiades C, Singh VK, Khashab M, Amateau S, Li Z, Okolo P, Lennon AM, Saxena P, Geschwind JF, Schlachter T, Hong K, Pawlik TM, Canto M, Law J, Sharaiha R, Weiss CR, Thuluvath P, Goggins M, Shin EJ, Peng H, Kumbhari V, Hutfless S, Zhou L, Mezey E, Meltzer SJ, Karchin R, Selaru FM. – Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology, 2014,Volume: 60,Issue: 3, Pages: 896-907, 11.055
Rani B, Cao Y, Malfettone A, Tomuleasa C, Fabregat I, Giannelli G. – Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World Journal Of Gastroenterology,2014 Volume: 20,Issue: 15, Pages: 4128-4140, 2.369
Aldea Mihaela ; Craciun Lucian ; Tomuleasa Ciprian; Crivii Carmen- The role of depression and neuroimmune axis in the prognosis of cancer patients , Journal Of Buon 2014,Volume: 19, Issue: 1,Pages: 5-14, 0.741
